col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: American Association for the Advancement of Science (AAAS)

1514 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Science Immunology 2024―Jul―12 Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium Kaixin Liang, Katherine C. Barnett, Martin Hsu, Wei-Chun Chou, Sachendra S. Bais, Kristina Riebe, et al. (+13)
2 [GO] Science Immunology 2024―Jul―12 A confusion of pathways: Discerning cell death mechanisms in SARS-CoV-2 infection Lok-Yin Roy Wong, Stanley Perlman
3 [GO] Science 2024―Jul―11 Drivers of epidemic dynamics in real time from daily digital COVID-19 measurements Michelle Kendall, Luca Ferretti, Chris Wymant, Daphne Tsallis, James Petrie, Andrea Di Francia, et al. (+7)
4 [GO] Science Translational Medicine 2024―Jul―03 PI3Kγ inhibition circumvents inflammation and vascular leak in SARS-CoV-2 and other infections Ryan M. Shepard, Anghesom Ghebremedhin, Isaraphorn Pratumchai, Sally R. Robinson, Courtney Betts, Jingjing Hu, et al. (+36)
5 [GO] Science Translational Medicine 2024―Jul―03 Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection Michael J. Peluso, Dylan Ryder, Robert R. Flavell, Yingbing Wang, Jelena Levi, Brian H. LaFranchi, et al. (+29)
6 [GO] Science Translational Medicine 2024―Jun―26 AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults Yingyun Cai, Seme Diallo, Kim Rosenthal, Kuishu Ren, Daniel J. Flores, Andrew Dippel, et al. (+31)
7 [GO] Science Immunology 2024―Jun―21 SARS-CoV-2 inflammation durably imprints memory CD4 T cells Sophie L. Gray-Gaillard, Sabrina M. Solis, Han M. Chen, Clarice Monteiro, Grace Ciabattoni, Marie I. Samanovic, et al. (+9)
8 [GO] Science Advances 2024―Jun―12 COVID-19 point-of-care tests can identify low-antibody individuals: In-depth immunoanalysis of boosting benefits in a healthy cohort Michael Mallory, Jennifer E. Munt, Tara M. Narowski, Izabella Castillo, Edwing Cuadra, Nora Pisanic, et al. (+14)
9 [GO] Science Translational Medicine 2024―Jun―12 Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence David J. Bean, Janet Monroe, Yan Mei Liang, Ella Borberg, Yasmeen Senussi, Zoe Swank, et al. (+4)
10 [GO] Science 2024―Jun―06 Global pandemic treaty stalls, again, over equity concerns Jon Cohen
11 [GO] Science Advances 2024―Jun―05 Epidemic outcomes following government responses to COVID-19: Insights from nearly 100,000 models Eran Bendavid, Chirag J. Patel
12 [GO] Science Advances 2024―Jun―05 Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2 Mohammed R. Shaker, Andrii Slonchak, Bahaa Al-mhanawi, Sean D. Morrison, Julian D. J. Sng, Justin Cooper-White, et al. (+2)
13 [GO] Science Advances 2024―May―31 Exploring the Big Data Paradox for various estimands using vaccination data from the global COVID-19 Trends and Impact Survey (CTIS) Youqi Yang, Walter Dempsey, Peisong Han, Yashwant Deshmukh, Sylvia Richardson, Brian Tom, Bhramar Mukherjee
14 [GO] Science Advances 2024―May―24 Longitudinal plasma proteomic analysis of 1117 hospitalized patients with COVID-19 identifies features associated with severity and outcomes Arthur Viode, Kinga K. Smolen, Patrick van Zalm, David Stevenson, Meenakshi Jha, Kenneth Parker, et al. (+3)
15 [GO] Science 2024―May―23 U.S. blocks funding for pandemic research group Jocelyn Kaiser
16 [GO] Science Translational Medicine 2024―May―22 The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses David R. Martinez, Fernando R. Moreira, Nicholas J. Catanzaro, Meghan V. Diefenbacher, Mark R. Zweigart, Kendra L. Gully, et al. (+26)
17 [GO] Science Translational Medicine 2024―May―15 Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays Barbara Mühlemann, Samuel H. Wilks, Lauren Baracco, Meriem Bekliz, Juan Manuel Carreño, Victor M. Corman, et al. (+40)
18 [GO] Science 2024―May―02 Pandemics and their accelerants The Human Disease: How We Create Pandemics, from Our Bodies to Our Beliefs Sabrina Sholts MIT Press, 2024. 352 pp. Christos Lynteris
19 [GO] Science 2024―Apr―30 A pandemic agreement is within reach Anita Cicero, Alexandra Phelan
20 [GO] Science Translational Medicine 2024―Apr―17 Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology Hoang Van Phan, Alexandra Tsitsiklis, Cole P. Maguire, Elias K. Haddad, Patrice M. Becker, Seunghee Kim-Schulze, et al. (+229)
21 [GO] Science Advances 2024―Apr―10 Developing nucleoside tailoring strategies against SARS-CoV-2 via ribonuclease targeting chimera Yuanqin Min, Wei Xiong, Wei Shen, Xingyu Liu, Qianqian Qi, Yuanyuan Zhang, et al. (+8)
22 [GO] Science Immunology 2024―Apr―05 AS03 adjuvant enhances the magnitude, persistence, and clonal breadth of memory B cell responses to a plant-based COVID-19 vaccine in humans Lilit Grigoryan, Yupeng Feng, Lorenza Bellusci, Lilin Lai, Bushra Wali, Madison Ellis, et al. (+17)
23 [GO] Science Advances 2024―Apr―03 ER-export and ARFRP1/AP-1-dependent delivery of SARS-CoV-2 Envelope to lysosomes controls late stages of viral replication Guy J. Pearson, Harriet V. Mears, Malgorzata Broncel, Ambrosius P. Snijders, David L. V. Bauer, Jeremy G. Carlton
24 [GO] Science 2024―Mar―28 Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model Bin Tan, Xiaoming Zhang, Ahmadullah Ansari, Prakash Jadhav, Haozhou Tan, Kan Li, et al. (+7)
25 [GO] Science 2024―Mar―21 Rifts over equity imperil WHO’s pandemic treaty Jon Cohen
26 [GO] Science 2024―Mar―14 Erratum for the Research Article “The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic” by M. Worobey et al .
27 [GO] Science Translational Medicine 2024―Mar―13 An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations Michael Westberg, Yichi Su, Xinzhi Zou, Pinghan Huang, Arjun Rustagi, Jaishree Garhyan, et al. (+16)
28 [GO] Science Advances 2024―Mar―06 Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer Shahad K. Alsaiari, Seba Nadeef, John L. Daristotle, William Rothwell, Bujie Du, Johnny Garcia, et al. (+12)
29 [GO] Science Advances 2024―Mar―01 How the COVID-19 pandemic signaled the demise of Antarctic exceptionalism Daniela Liggett, Bob Frame, Peter Convey, Kevin A. Hughes
30 [GO] Science Advances 2024―Feb―28 Rise in broadly cross-reactive adaptive immunity against human β-coronaviruses in MERS-recovered patients during the COVID-19 pandemic So-Hee Kim, Yuri Kim, Sangeun Jeon, Uni Park, Ju-Il Kang, Kyeongseok Jeon, et al. (+15)
31 [GO] Science Advances 2024―Feb―28 Synthesis, insertion, and characterization of SARS-CoV-2 membrane protein within lipid bilayers Yuanzhong Zhang, Sara Anbir, Joseph McTiernan, Siyu Li, Michael Worcester, Pratyasha Mishra, et al. (+5)
32 [GO] Science 2024―Feb―22 Solving the puzzle of Long Covid Ziyad Al-Aly, Eric Topol
33 [GO] Science Advances 2024―Feb―21 Spontaneous, persistent, T cell-dependent IFN-γ release in patients who progress to Long Covid Benjamin A. Krishna, Eleanor Y. Lim, Marina Metaxaki, Sarah Jackson, Lenette Mactavous, Paul A. Lyons, et al. (+8)
34 [GO] Science Immunology 2024―Feb―09 Mucosal and systemic immune correlates of viral control after SARS-CoV-2 infection challenge in seronegative adults Helen R. Wagstaffe, Ryan S. Thwaites, Arnold Reynaldi, Jasmin K. Sidhu, Richard McKendry, Stephanie Ascough, et al. (+13)
35 [GO] Science 2024―Feb―08 Erratum for the Research Article “Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain” by K. G. Nabel et al .
36 [GO] Science Advances 2024―Jan―26 Climate change, society, and pandemic disease in Roman Italy between 200 BCE and 600 CE Karin A. F. Zonneveld, Kyle Harper, Andreas Klügel, Liang Chen, Gert De Lange, Gerard J. M. Versteegh
37 [GO] Science 2024―Jan―25 SARS-CoV-2 sneezing explained Mitch Leslie
38 [GO] Science Translational Medicine 2024―Jan―24 SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency Yijia Li, Manish C. Choudhary, James Regan, Julie Boucau, Anusha Nathan, Tessa Speidel, et al. (+27)
39 [GO] Science 2024―Jan―18 Immune damage in Long Covid Wolfram Ruf
40 [GO] Science 2024―Jan―18 Persistent complement dysregulation with signs of thromboinflammation in active Long Covid Carlo Cervia-Hasler, Sarah C. Brüningk, Tobias Hoch, Bowen Fan, Giulia Muzio, Ryan C. Thompson, et al. (+22)
41 [GO] Science Translational Medicine 2024―Jan―03 Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates Madhu Prabhakaran, Flavio Matassoli, David Leggat, Abigayle Hoover, Abhinaya Srikanth, Weiwei Wu, et al. (+21)
42 [GO] Science Advances 2024―Jan―03 Adaptive immune cells are necessary for SARS-CoV-2-induced pathology Brian Imbiakha, Julie M. Sahler, David W. Buchholz, Shahrzad Ezzatpour, Mason Jager, Annette Choi, et al. (+9)
43 [GO] Science Advances 2023―Dec―20 Transformation of social relationships in COVID-19 America: Remote communication may amplify political echo chambers Byungkyu Lee, Kangsan Lee, Benjamin Hartmann
44 [GO] Science Advances 2023―Dec―20 Design and analysis heterogeneity in observational studies of COVID-19 booster effectiveness: A review and case study Sabir Meah, Xu Shi, Lars G. Fritsche, Maxwell Salvatore, Abram Wagner, Emily T. Martin, Bhramar Mukherjee
45 [GO] Science Signaling 2023―Dec―19 Inhibition of the lysine demethylase LSD1 modulates the balance between inflammatory and antiviral responses against coronaviruses Luca Mazzarella, Fabio Santoro, Roberto Ravasio, Valeria Fumagalli, Paul E. Massa, Simona Rodighiero, et al. (+24)
46 [GO] Science Immunology 2023―Dec―08 SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19 Curtis Cai, Yu Gao, Sarah Adamo, Olga Rivera-Ballesteros, Lotta Hansson, Anders Österborg, et al. (+14)
47 [GO] Science 2023―Dec―07 Rare studies expose bats to SARS-CoV-2 Jon Cohen
48 [GO] Science Translational Medicine 2023―Dec―06 USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice Fabin Dang, Lei Bai, Jiazhen Dong, Xiaoping Hu, Jingchao Wang, Joao A. Paulo, et al. (+21)
49 [GO] Science Advances 2023―Dec―01 Excess mortality in U.S. prisons during the COVID-19 pandemic Naomi F. Sugie, Kristin Turney, Keramet Reiter, Rebecca Tublitz, Daniela Kaiser, Rebecca Goodsell, et al. (+3)
50 [GO] Science Translational Medicine 2023―Nov―29 T cell responses to SARS-CoV-2 infection and vaccination are elevated in B cell deficiency and reduce risk of severe COVID-19 Reza Zonozi, Lucy C. Walters, Aaron Shulkin, Vivek Naranbhai, Pravarut Nithagon, Gabriel Sauvage, et al. (+20)
51 [GO] Science 2023―Nov―23 Novel coronavirus blamed for Cyprus cat deaths Catherine Offord
52 [GO] Science Immunology 2023―Nov―17 Enhanced SARS-CoV-2 humoral immunity following breakthrough infection builds upon the preexisting memory B cell pool Timm Weber, Sabrina Dähling, Svea Rose, Patrick Affeldt, Kanika Vanshylla, Leon Ullrich, et al. (+9)
53 [GO] Science 2023―Nov―09 Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors Melissa L. Boby, Daren Fearon, Matteo Ferla, Mihajlo Filep, Lizbé Koekemoer, Matthew C. Robinson, et al. (+206)
54 [GO] Science 2023―Nov―09 Preparing for the next pandemic Brian K. Shoichet, Charles S. Craik
55 [GO] Science 2023―Oct―26 Billions boost next-generation weapons against SARS-CoV-2 Jon Cohen
56 [GO] Science Translational Medicine 2023―Oct―18 Many potential pathways to future pandemic influenza David M. Morens, Jaekeun Park, Jeffery K. Taubenberger
57 [GO] Science Advances 2023―Oct―13 Atomic structure of the open SARS-CoV-2 E viroporin João Medeiros-Silva, Aurelio J. Dregni, Noah H. Somberg, Pu Duan, Mei Hong
58 [GO] Science Advances 2023―Oct―12 First-in-human immunoPET imaging of COVID-19 convalescent patients using dynamic total-body PET and a CD8-targeted minibody Negar Omidvari, Terry Jones, Pat M. Price, April L. Ferre, Jacqueline Lu, Yasser G. Abdelhafez, et al. (+7)
59 [GO] Science Advances 2023―Oct―12 Characterization of the antispike IgG immune response to COVID-19 vaccines in people with a wide variety of immunodeficiencies Mackenzie Zendt, Fausto A. Bustos Carrillo, Sophie Kelly, Taylor Saturday, Maureen DeGrange, Anita Ginigeme, et al. (+41)
60 [GO] Science 2023―Oct―12 Variant-adapted COVID-19 booster vaccines Florian Krammer, Ali H. Ellebedy
61 [GO] Science 2023―Oct―12 Award honors pair for mRNA work key to COVID-19 vaccines Catherine Offord, Jon Cohen
62 [GO] Science 2023―Oct―12 Erratum for the Research Article “The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2” by J. E. Pekar et al.
63 [GO] Science 2023―Oct―11 Mapping SARS-CoV-2 antigenic relationships and serological responses Samuel H. Wilks, Barbara Mühlemann, Xiaoying Shen, Sina Türeli, Eric B. LeGresley, Antonia Netzl, et al. (+26)
64 [GO] Science 2023―Sep―28 MRI study charts organ damage months after COVID-19 Catherine Offord
65 [GO] Science 2023―Sep―28 Pandemics and their lessons Foreign Bodies: Pandemics, Vaccines, and the Health of Nations Simon Schama Ecco, 2023. 480 pp. Michael A. Goldman
66 [GO] Science Translational Medicine 2023―Sep―27 A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus Longping V. Tse, Yixuan J. Hou, Elizabeth McFadden, Rhianna E. Lee, Trevor D. Scobey, Sarah R. Leist, et al. (+12)
67 [GO] Science Signaling 2023―Sep―26 Transcriptomics-inferred dynamics of SARS-CoV-2 interactions with host epithelial cells Lukas Adam, Megan Stanifer, Fabian Springer, Jan Mathony, Maik Brune, Chiara Di Ponzio, et al. (+4)
68 [GO] Science Advances 2023―Sep―22 Unexpected vaginal bleeding and COVID-19 vaccination in nonmenstruating women Kristine Blix, Ida Laake, Lene Juvet, Anna Hayman Robertson, Ida Henriette Caspersen, Siri Mjaaland, et al. (+4)
69 [GO] Science Advances 2023―Sep―22 Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection Gabriela Baldeon Vaca, Michelle Meyer, Ana Cadete, Chiaowen Joyce Hsiao, Anne Golding, Albert Jeon, et al. (+14)
70 [GO] Science Advances 2023―Sep―22 Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5 Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, Julie Sahler, Chengjin Ye, Ximena A. Olarte-Castillo, et al. (+12)
71 [GO] Science Advances 2023―Sep―15 The efficacy of Facebook’s vaccine misinformation policies and architecture during the COVID-19 pandemic David A. Broniatowski, Joseph R. Simons, Jiayan Gu, Amelia M. Jamison, Lorien C. Abroms
72 [GO] Science Translational Medicine 2023―Sep―13 Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2 Guillaume B. E. Stewart-Jones, Sayda M. Elbashir, Kai Wu, Diana Lee, Isabella Renzi, Baoling Ying, et al. (+19)
73 [GO] Science Translational Medicine 2023―Sep―06 Humoral immunity to an endemic coronavirus is associated with postacute sequelae of COVID-19 in individuals with rheumatic diseases Jonathan D. Herman, Caroline Atyeo, Yonatan Zur, Claire E. Cook, Naomi J. Patel, Kathleen M. Vanni, et al. (+11)
74 [GO] Science Immunology 2023―Sep―01 The HLA advantage: Why COVID-19 benched you but not your co-worker Nisha Saif, Gabriel K. Griffin
75 [GO] Science Translational Medicine 2023―Aug―30 An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models Emiko Urano, Yumi Itoh, Tatsuya Suzuki, Takanori Sasaki, Jun-ichi Kishikawa, Kanako Akamatsu, et al. (+26)
76 [GO] Science 2023―Aug―24 Will climate change amplify epidemics and give rise to pandemics? Tulio de Oliveira, Houriiyah Tegally
77 [GO] Science Translational Medicine 2023―Aug―23 A complement atlas identifies interleukin-6-dependent alternative pathway dysregulation as a key druggable feature of COVID-19 Karel F. A. Van Damme, Levi Hoste, Jozefien Declercq, Elisabeth De Leeuw, Bastiaan Maes, Liesbet Martens, et al. (+17)
78 [GO] Science Signaling 2023―Aug―15 Broadening a SARS-CoV-1-neutralizing antibody for potent SARS-CoV-2 neutralization through directed evolution Fangzhu Zhao, Meng Yuan, Celina Keating, Namir Shaabani, Oliver Limbo, Collin Joyce, et al. (+16)
79 [GO] Science Immunology 2023―Aug―11 Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation Oyebola O. Oyesola, Kerry L. Hilligan, Sivaranjani Namasivayam, Nina Howard, Chad S. Clancy, Mingming Zhao, et al. (+8)
80 [GO] Science Translational Medicine 2023―Aug―09 Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts Joseph W. Guarnieri, Joseph M. Dybas, Hossein Fazelinia, Man S. Kim, Justin Frere, Yuanchao Zhang, et al. (+45)
81 [GO] Science Advances 2023―Aug―02 Quantifying the impact of SARS-CoV-2 temporal vaccination trends and disparities on disease control Sophie L. Larsen, Ikgyu Shin, Jefrin Joseph, Haylee West, Rafael Anorga, Gonzalo E. Mena, et al. (+2)
82 [GO] Science Advances 2023―Jul―28 The worldwide COVID-19 lockdown impacts on global secondary inorganic aerosols and radiative budget Takashi Sekiya, Kazuyuki Miyazaki, Henk Eskes, Kevin Bowman, Kengo Sudo, Yugo Kanaya, Masayuki Takigawa
83 [GO] Science Immunology 2023―Jul―28 Modulation of type I interferon responses potently inhibits SARS-CoV-2 replication and inflammation in rhesus macaques Elise G. Viox, Timothy N. Hoang, Amit A. Upadhyay, Rayhane Nchioua, Maximilian Hirschenberger, Zachary Strongin, et al. (+36)
84 [GO] Science 2023―Jul―20 Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1 Joseph L.-H. Tsui, John T. McCrone, Ben Lambert, Sumali Bajaj, Rhys P. D. Inward, Paolo Bosetti, et al. (+34)
85 [GO] Science Translational Medicine 2023―Jul―12 Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states Thomas R. Müller, Takuya Sekine, Darya Trubach, Julia Niessl, Puran Chen, Peter Bergman, et al. (+21)
86 [GO] Science 2023―Jul―06 Studies probe COVID-19 shots’ link to rare symptoms Gretchen Vogel, Jennifer Couzin-Frankel
87 [GO] Science Immunology 2023―Jun―30 HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation Hongbing Yang, Hong Sun, Simon Brackenridge, Xiaodong Zhuang, Peter A C Wing, Max Quastel, et al. (+23)
88 [GO] Science 2023―Jun―29 Scientists, U.S. counter claims of pandemic patient zero at lab Jon Cohen
89 [GO] Science Advances 2023―Jun―23 Monthly excess mortality across counties in the United States during the COVID-19 pandemic, March 2020 to February 2022 Eugenio Paglino, Dielle J. Lundberg, Zhenwei Zhou, Joe A. Wasserman, Rafeya Raquib, Anneliese N. Luck, et al. (+5)
90 [GO] Science Advances 2023―Jun―23 A SARS-CoV-2 and influenza double hit vaccine based on RBD-conjugated inactivated influenza A virus Zhenzhen Wang, Zhenhua Li, Weiwei Shi, Dashuai Zhu, Shiqi Hu, Phuong-Uyen C. Dinh, Ke Cheng
91 [GO] Science 2023―Jun―22 Could chatbots help devise the next pandemic virus? Robert F. Service
92 [GO] Science Advances 2023―Jun―21 Pharmacological modulators of epithelial immunity uncovered by synthetic genetic tracing of SARS-CoV-2 infection responses Ben Jiang, Matthias Jürgen Schmitt, Ulfert Rand, Carlos Company, Yuliia Dramaretska, Melanie Grossmann, et al. (+3)
93 [GO] Science Advances 2023―Jun―14 Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates Qian-Fang Meng, Wanbo Tai, Mingyao Tian, Xinyu Zhuang, Yuanwei Pan, Jialin Lai, et al. (+12)
94 [GO] Science Advances 2023―Jun―14 CD62L expression marks SARS-CoV-2 memory B cell subset with preference for neutralizing epitopes Taishi Onodera, Nicolas Sax, Takashi Sato, Yu Adachi, Ryutaro Kotaki, Takeshi Inoue, et al. (+19)
95 [GO] Science Signaling 2023―Jun―13 Delayed engagement of host defenses enables SARS-CoV-2 viremia and productive infection of distal organs in the hamster model of COVID-19 Lucia Carrau, Justin J. Frere, Ilona Golynker, Alvaro Fajardo, Cristobal F. Rivera, Shu Horiuchi, et al. (+4)
96 [GO] Science Advances 2023―Jun―09 Alternative epidemic indicators for COVID-19 in three settings with incomplete death registration systems Ruth McCabe, Charles Whittaker, Richard J. Sheppard, Nada Abdelmagid, Aljaile Ahmed, Israa Zain Alabdeen, et al. (+24)
97 [GO] Science 2023―Jun―08 Companies hoard COVID-19 vaccines, stalling future research Jon Cohen
98 [GO] Science 2023―Jun―08 Behavioral responses of terrestrial mammals to COVID-19 lockdowns Marlee A. Tucker, Aafke M. Schipper, Tempe S. F. Adams, Nina Attias, Tal Avgar, Natarsha L. Babic, et al. (+168)
99 [GO] Science Advances 2023―Jun―07 SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity Ramón Martínez-Mármol, Rosina Giordano-Santini, Eva Kaulich, Ann-Na Cho, Magdalena Przybyla, Md Asrafuzzaman Riyadh, et al. (+9)
100 [GO] Science Advances 2023―Jun―07 Structural and computational design of a SARS-CoV-2 spike antigen with improved expression and immunogenicity James A. Williams, Marco Biancucci, Laura Lessen, Sai Tian, Ankita Balsaraf, Lynn Chen, et al. (+10)
101 [GO] Science 2023―May―25 New antibodies that the coronavirus can’t elude Robert F. Service
102 [GO] Science 2023―May―25 Decision nears for fall coronavirus vaccine Jennifer Couzin-Frankel
103 [GO] Science 2023―May―25 Implementation, compliance, and pandemic legal obligations Mark Eccleston-Turner, Gian-Luca Burci, Jonathan Liberman, Sharifah Sekalala
104 [GO] Science Translational Medicine 2023―May―24 A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo Clare Burn Aschner, Krithika Muthuraman, Iga Kucharska, Hong Cui, Katherine Prieto, Manoj S. Nair, et al. (+14)
105 [GO] Science Immunology 2023―May―16 Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates Nanda Kishore Routhu, Samuel David Stampfer, Lilin Lai, Akil Akhtar, Xin Tong, Dansu Yuan, et al. (+22)
106 [GO] Science 2023―May―11 End of COVID-19 emergencies sparks debate Kai Kupferschmidt, Meredith Wadman
107 [GO] Science Translational Medicine 2023―May―10 Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine Yupeng Feng, Meng Yuan, John M. Powers, Mengyun Hu, Jennifer E. Munt, Prabhu S. Arunachalam, et al. (+21)
108 [GO] Science Signaling 2023―May―09 SARS-CoV-2 airway infection results in the development of somatosensory abnormalities in a hamster model Randal A. Serafini, Justin J. Frere, Jeffrey Zimering, Ilinca M. Giosan, Kerri D. Pryce, Ilona Golynker, et al. (+4)
109 [GO] Science Immunology 2023―May―05 Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis Anis Barmada, Jon Klein, Anjali Ramaswamy, Nina N. Brodsky, Jillian R. Jaycox, Hassan Sheikha, et al. (+17)
110 [GO] Science 2023―May―04 Cascading failures in COVID-19 vaccine equity James V. Lavery, Rachael M. Porter, David G. Addiss
111 [GO] Science Signaling 2023―May―02 The substrate selectivity of papain-like proteases from human-infecting coronaviruses correlates with innate immune suppression Yuxian Xiong, Bin Huang, Ying Yang, Xinming Fu, Ziyang Fu, Huidong Xu, et al. (+7)
112 [GO] Science Signaling 2023―May―02 The SARS-CoV-2 papain-like protease suppresses type I interferon responses by deubiquitinating STING Dan Cao, Lian Duan, Bin Huang, Yuxian Xiong, Guoliang Zhang, Hao Huang
113 [GO] Science Signaling 2023―Apr―25 Macrophage ACE2 is necessary for SARS-CoV-2 replication and subsequent cytokine responses that restrict continued virion release Larisa I. Labzin, Keng Yih Chew, Kathrin Eschke, Xiaohui Wang, Tyron Esposito, Claudia J. Stocks, et al. (+18)
114 [GO] Science Translational Medicine 2023―Apr―19 Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial David Benkeser, David C. Montefiori, Adrian B. McDermott, Youyi Fong, Holly E. Janes, Weiping Deng, et al. (+39)
115 [GO] Science Advances 2023―Apr―10 Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors Seyed Arad Moghadasi, Emmanuel Heilmann, Ahmed Magdy Khalil, Christina Nnabuife, Fiona L. Kearns, Chengjin Ye, et al. (+9)
116 [GO] Science Advances 2023―Apr―07 The critical role of engineering in the rapid development of COVID-19 diagnostics: Lessons from the RADx Tech Test Verification Core Robert G. Mannino, Eric J. Nehl, Sarah Farmer, Amanda Foster Peagler, Maren C. Parsell, Viviana Claveria, et al. (+5)
117 [GO] Science 2023―Apr―06 Share all SARS-CoV-2 data immediately Maria D. Van Kerkhove
118 [GO] Science 2023―Apr―06 Dispute simmers over who first shared SARS-CoV-2’s genome Martin Enserink
119 [GO] Science Advances 2023―Apr―05 A conserved oligomerization domain in the disordered linker of coronavirus nucleocapsid proteins Huaying Zhao, Di Wu, Sergio A. Hassan, Ai Nguyen, Jiji Chen, Grzegorz Piszczek, Peter Schuck
120 [GO] Science Translational Medicine 2023―Apr―05 Pandemic preparedness strategies must go beyond vaccines Rajesh Gupta, Lisa A. Purcell, Davide Corti, Herbert W. Virgin
121 [GO] Science Advances 2023―Mar―31 Human disturbance increases coronavirus prevalence in bats Vera M. Warmuth, Dirk Metzler, Veronica Zamora-Gutierrez
122 [GO] Science 2023―Mar―31 Could a popular antiviral supercharge the pandemic? Robert F. Service
123 [GO] Science 2023―Mar―23 New clues to pandemic’s origin surface, causing uproar Jon Cohen
124 [GO] Science 2023―Mar―23 New Long Covid cases decline with Omicron Jennifer Couzin-Frankel
125 [GO] Science Translational Medicine 2023―Mar―22 Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers Pete Schmidt, Kristin Narayan, Yong Li, Chengzi I. Kaku, Michael E. Brown, Elizabeth Champney, et al. (+10)
126 [GO] Science 2023―Mar―16 Do COVID-19 vaccine mandates still make sense? Gretchen Vogel
127 [GO] Science Translational Medicine 2023―Mar―15 Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination Véronique Barateau, Loïc Peyrot, Carla Saade, Bruno Pozzetto, Karen Brengel-Pesce, Mad-Hélénie Elsensohn, et al. (+22)
128 [GO] Science Immunology 2023―Feb―23 Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19 Bibo Zhu, Xiaoqin Wei, Harish Narasimhan, Wei Qian, Ruixuan Zhang, In Su Cheon, et al. (+14)
129 [GO] Science Translational Medicine 2023―Feb―15 An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, et al. (+19)
130 [GO] Science 2023―Feb―02 The NIH-led research response to COVID-19 Francis Collins, Stacey Adam, Christine Colvis, Elizabeth Desrosiers, Ruxandra Draghia-Akli, Anthony Fauci, et al. (+26)
131 [GO] Science 2023―Feb―02 Protein decoys may battle COVID-19 and more Robert F. Service
132 [GO] Science 2023―Feb―02 New COVID-19 vaccine strategy would mimic flu’s annual shots Jennifer Couzin-Frankel
133 [GO] Science 2023―Feb―02 Managing sources of error during pandemics Simon Cauchemez, Paolo Bosetti, Benjamin J. Cowling
134 [GO] Science Immunology 2023―Jan―26 Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein Filippo Bianchini, Virginia Crivelli, Morgan E. Abernathy, Concetta Guerra, Martin Palus, Jonathan Muri, et al. (+40)
135 [GO] Science Advances 2023―Jan―20 Altered host protease determinants for SARS-CoV-2 Omicron Jasper Fuk-Woo Chan, Xiner Huang, Bingjie Hu, Yue Chai, Hongyu Shi, Tianrenzheng Zhu, et al. (+18)
136 [GO] Science Advances 2023―Jan―18 Using digital traces to build prospective and real-time county-level early warning systems to anticipate COVID-19 outbreaks in the United States Lucas M. Stolerman, Leonardo Clemente, Canelle Poirier, Kris V. Parag, Atreyee Majumder, Serge Masyn, et al. (+2)
137 [GO] Science 2023―Jan―05 China is flying blind as the pandemic rages Dennis Normile
138 [GO] Science Advances 2023―Jan―04 Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19 Gustaf Wigerblad, Seth A. Warner, Marcos J. Ramos-Benitez, Lela Kardava, Xin Tian, Rui Miao, et al. (+16)
139 [GO] Science Translational Medicine 2023―Jan―04 Vaccination with S pan , an antigen guided by SARS-CoV-2 S protein evolution, protects against challenge with viral variants in mice Yongliang Zhao, Wenjia Ni, Simeng Liang, Lianghui Dong, Min Xiang, Zeng Cai, et al. (+17)
140 [GO] Science Advances 2022―Dec―23 The D614G mutation redirects SARS-CoV-2 spike to lysosomes and suppresses deleterious traits of the furin cleavage site insertion mutation Chenxu Guo, Shang-Jui Tsai, Yiwei Ai, Maggie Li, Eduardo Anaya, Andrew Pekosz, et al. (+2)
141 [GO] Science Advances 2022―Dec―23 Manganese-coordinated mRNA vaccines with enhanced mRNA expression and immunogenicity induce robust immune responses against SARS-CoV-2 variants Na Fan, Kepan Chen, Rong Zhu, Zhongwei Zhang, Hai Huang, Shugang Qin, et al. (+12)
142 [GO] Science Advances 2022―Dec―23 Erratum for the Research Article: “Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern”
143 [GO] Science Immunology 2022―Dec―22 Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination Pascal Irrgang, Juliane Gerling, Katharina Kocher, Dennis Lapuente, Philipp Steininger, Katharina Habenicht, et al. (+17)
144 [GO] Science Advances 2022―Dec―21 Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system Yuyong Zhou, Karen Anbro Gammeltoft, Line Abildgaard Ryberg, Long V. Pham, Helena Damtoft Tjørnelund, Alekxander Binderup, et al. (+8)
145 [GO] Science 2022―Dec―20 Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children Danyel Lee, Jérémie Le Pen, Ahmad Yatim, Beihua Dong, Yann Aquino, Masato Ogishi, et al. (+97)
146 [GO] Science 2022―Dec―15 Pandemic vaccine equity plan may soon start winding down Gretchen Vogel
147 [GO] Science Advances 2022―Dec―09 Biochemical and structural insights into SARS-CoV-2 polyprotein processing by Mpro Ruchi Yadav, Valentine V. Courouble, Sanjay K. Dey, Jerry Joe E. K. Harrison, Jennifer Timm, Jesse B. Hopkins, et al. (+5)
148 [GO] Science Advances 2022―Dec―09 Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions Shaun M. Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel R. Landau, Eli Rothenberg
149 [GO] Science Advances 2022―Dec―07 Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo James A. Torchia, Alexander H. Tavares, Laura S. Carstensen, Da-Yuan Chen, Jessie Huang, Tianshu Xiao, et al. (+10)
150 [GO] Science Translational Medicine 2022―Dec―01 Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later Emma C. Milligan, Katherine Olstad, Caitlin A. Williams, Michael Mallory, Patricio Cano, Kaitlyn A. Cross, et al. (+36)
151 [GO] Science 2022―Dec―01 Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa Carlo Fischer, Tongai Gibson Maponga, Anges Yadouleton, Nuro Abílio, Emmanuel Aboce, Praise Adewumi, et al. (+82)
152 [GO] Science 2022―Dec―01 Pandemic accelerates ‘GRExit’ Katie Langin
153 [GO] Science Advances 2022―Nov―30 The SARS-CoV-2 spike protein binds and modulates estrogen receptors Oscar Solis, Andrea R. Beccari, Daniela Iaconis, Carmine Talarico, Camilo A. Ruiz-Bedoya, Jerome C. Nwachukwu, et al. (+25)
154 [GO] Science Advances 2022―Nov―23 The free fatty acid-binding pocket is a conserved hallmark in pathogenic β-coronavirus spike proteins from SARS-CoV to Omicron Christine Toelzer, Kapil Gupta, Sathish K. N. Yadav, Lorna Hodgson, Maia Kavanagh Williamson, Dora Buzas, et al. (+14)
155 [GO] Science Advances 2022―Nov―23 Protection against SARS-CoV-2 Omicron BA.1 variant challenge in macaques by prime-boost vaccination with Ad26.COV2.S and SpFN Jingyou Yu, Paul V. Thomas, Katherine McMahan, Catherine Jacob-Dolan, Jinyan Liu, Xuan He, et al. (+36)
156 [GO] Science Advances 2022―Nov―23 Probing the biophysical constraints of SARS-CoV-2 spike N-terminal domain using deep mutational scanning Wenhao O. Ouyang, Timothy J.C. Tan, Ruipeng Lei, Ge Song, Collin Kieffer, Raiees Andrabi, et al. (+2)
157 [GO] Science Advances 2022―Nov―18 SARS-CoV-2 Omicron BA.1 and BA.2 are attenuated in rhesus macaques as compared to Delta Neeltje van Doremalen, Manmeet Singh, Taylor A. Saturday, Claude Kwe Yinda, Lizzette Perez-Perez, W. Forrest Bohler, et al. (+15)
158 [GO] Science 2022―Nov―17 COVID-19 vaccination and menstruation Victoria Male
159 [GO] Science Advances 2022―Nov―11 High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines Darawan Rinchai, Sara Deola, Gabriele Zoppoli, Basirudeen Syed Ahamed Kabeer, Sara Taleb, Igor Pavlovski, et al. (+36)
160 [GO] Science Immunology 2022―Nov―10 SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines John E. Bowen, Young-Jun Park, Cameron Stewart, Jack T. Brown, William K. Sharkey, Alexandra C. Walls, et al. (+34)
161 [GO] Science Translational Medicine 2022―Nov―08 Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data Sarah A. Nadeau, Timothy G. Vaughan, Christiane Beckmann, Ivan Topolsky, Chaoran Chen, Emma Hodcroft, et al. (+42)
162 [GO] Science Translational Medicine 2022―Nov―03 S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hiroko Kobayashi, Takuma Ariizumi, et al. (+16)
163 [GO] Science Immunology 2022―Nov―01 Durable spike-specific T-cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination Yacine Maringer, Annika Nelde, Sarah M. Schroeder, Juliane Schuhmacher, Sebastian Hörber, Andreas Peter, et al. (+3)
164 [GO] Science Advances 2022―Oct―26 De novo selected hACE2 mimics that integrate hotspot peptides with aptameric scaffolds for binding tolerance of SARS-CoV-2 variants Minjong Lee, Byunghwa Kang, Juhwa Lee, Jisun Lee, Sang Taek Jung, Chang Yun Son, Seung Soo Oh
165 [GO] Science Signaling 2022―Oct―25 Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication Tomer M. Yaron, Brook E. Heaton, Tyler M. Levy, Jared L. Johnson, Tristan X. Jordan, Benjamin M. Cohen, et al. (+41)
166 [GO] Science 2022―Oct―20 Heart risks fuel debate over COVID-19 boosters Jennifer Couzin-Frankel
167 [GO] Science 2022―Oct―20 Imprinted antibody responses against SARS-CoV-2 Omicron sublineages Young-Jun Park, Dora Pinto, Alexandra C. Walls, Zhuoming Liu, Anna De Marco, Fabio Benigni, et al. (+46)
168 [GO] Science 2022―Oct―20 Erratum for the Research Article “Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome,” by P. R. Bhatt et al .
169 [GO] Science Advances 2022―Oct―17 Policies to influence perceptions about COVID-19 risk: The case of maps Claudia Engel, Jonathan Rodden, Marco Tabellini
170 [GO] Science 2022―Oct―13 Evidence backs natural origin for pandemic, report asserts Jon Cohen
171 [GO] Science Advances 2022―Oct―07 Severe COVID-19 induces autoantibodies against angiotensin II that correlate with blood pressure dysregulation and disease severity Priscilla S. Briquez, Sherin J. Rouhani, Jovian Yu, Athalia R. Pyzer, Jonathan Trujillo, Haley L. Dugan, et al. (+7)
172 [GO] Science 2022―Oct―06 Partisanship and the pandemic Pandemic Politics Shana Kushner Gadarian, Sara Wallace Goodman, and Thomas B. Pepinsky Princeton University Press, 2022. 400 pp. Matthew S. Levendusky
173 [GO] Science Advances 2022―Oct―05 Structural insights for neutralization of Omicron variants BA.1, BA.2, BA.4, and BA.5 by a broadly neutralizing SARS-CoV-2 antibody Sanjeev Kumar, Anamika Patel, Lilin Lai, Chennareddy Chakravarthy, Rajesh Valanparambil, Elluri Seetharami Reddy, et al. (+28)
174 [GO] Science Translational Medicine 2022―Oct―04 SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376 Emmanuel Heilmann, Francesco Costacurta, Seyed Arad Moghadasi, Chengjin Ye, Matteo Pavan, Davide Bassani, et al. (+9)
175 [GO] Science Advances 2022―Sep―30 COVID-19 Exposure Assessment Tool (CEAT): Exposure quantification based on ventilation, infection prevalence, group characteristics, and behavior Brian J. Schimmoller, Nídia S. Trovão, Molly Isbell, Chirag Goel, Benjamin F. Heck, Tenley C. Archer, et al. (+5)
176 [GO] Science 2022―Sep―29 New Omicron strains may portend big COVID-19 waves Gretchen Vogel
177 [GO] Science 2022―Sep―29 University pandemic policies raise equity worries Katie Langin
178 [GO] Science Advances 2022―Sep―28 Losing the battle over best-science guidance early in a crisis: COVID-19 and beyond Lucia Illari, Nicholas J. Restrepo, Neil F. Johnson
179 [GO] Science Advances 2022―Sep―28 Microfluidic affinity selection of active SARS-CoV-2 virus particles Sachindra S. T. Gamage, Thilanga N. Pahattuge, Harshani Wijerathne, Katie Childers, Swarnagowri Vaidyanathan, Uditha S. Athapattu, et al. (+16)
180 [GO] Science Advances 2022―Sep―23 Role for N -glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity Qi Yang, Anju Kelkar, Anirudh Sriram, Ryoma Hombu, Thomas A. Hughes, Sriram Neelamegham
181 [GO] Science Translational Medicine 2022―Sep―22 SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages Giovanny J. Martínez-Colón, Kalani Ratnasiri, Heping Chen, Sizun Jiang, Elizabeth Zanley, Arjun Rustagi, et al. (+12)
182 [GO] Science Advances 2022―Sep―21 SARS-CoV-2 disrupts respiratory vascular barriers by suppressing Claudin-5 expression Rina Hashimoto, Junya Takahashi, Keisuke Shirakura, Risa Funatsu, Kaori Kosugi, Sayaka Deguchi, et al. (+26)
183 [GO] Science Advances 2022―Sep―16 Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern Sylwia D. Tyrkalska, Alicia Martínez-López, Ana B. Arroyo, Francisco J. Martínez-Morcillo, Sergio Candel, Diana García-Moreno, et al. (+3)
184 [GO] Science 2022―Sep―15 The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance Houriiyah Tegally, James E. San, Matthew Cotten, Monika Moir, Bryan Tegomoh, Gerald Mboowa, et al. (+395)
185 [GO] Science 2022―Sep―15 Private venture tackles Long Covid, aims to test drugs soon Jennifer Couzin-Frankel
186 [GO] Science Translational Medicine 2022―Sep―14 A shift in lung macrophage composition is associated with COVID-19 severity and recovery Steven T. Chen, Matthew D. Park, Diane Marie Del Valle, Mark Buckup, Alexandra Tabachnikova, Ryan C. Thompson, et al. (+30)
187 [GO] Science Advances 2022―Sep―14 Identification of immunomodulatory drugs that inhibit multiple inflammasomes and impair SARS-CoV-2 infection Letícia de Almeida, Alexandre L. N. da Silva, Tamara S. Rodrigues, Samuel Oliveira, Adriene Y. Ishimoto, Amanda A. Seribelli, et al. (+19)
188 [GO] Science Translational Medicine 2022―Sep―14 Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models Renee L. Hajnik, Jessica A. Plante, Yuejin Liang, Mohamad-Gabriel Alameh, Jinyi Tang, Srinivasa Reddy Bonam, et al. (+16)
189 [GO] Science Advances 2022―Sep―14 Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response Thayne H. Dickey, Wai Kwan Tang, Brandi Butler, Tarik Ouahes, Sachy Orr-Gonzalez, Nichole D. Salinas, et al. (+2)
190 [GO] Science Immunology 2022―Sep―09 Sensing of SARS-CoV-2 by pDCs and their subsequent production of IFN-I contribute to macrophage-induced cytokine storm during COVID-19 Paôline Laurent, Chao Yang, André F. Rendeiro, Benjamin E. Nilsson-Payant, Lucia Carrau, Vasuretha Chandar, et al. (+6)
191 [GO] Science 2022―Sep―08 COVID-19 and children Carl A. Pierce, Kevan C. Herold, Betsy C. Herold, Janet Chou, Adrienne Randolph, Binita Kane, et al. (+6)
192 [GO] Science 2022―Aug―25 Wildlife trade is likely the source of SARS-CoV-2 Xiaowei Jiang, Ruoqi Wang
193 [GO] Science Advances 2022―Aug―24 (E1)levating COVID-19 vaccine efficiency with adenoviral E1 proteins Douglas R. Green, Paul G. Thomas
194 [GO] Science Advances 2022―Aug―24 Comparison of replicating and nonreplicating vaccines against SARS-CoV-2 Haley E. Mudrick, Shane Massey, Erin B. McGlinch, Brian J. Parrett, Jack R. Hemsath, Mary E. Barry, et al. (+14)
195 [GO] Science Advances 2022―Aug―24 Femtomolar detection of SARS-CoV-2 via peptide beacons integrated on a miniaturized TIRF microscope Soumya P. Tripathy, Manvitha Ponnapati, Suhaas Bhat, Joseph Jacobson, Pranam Chatterjee
196 [GO] Science Advances 2022―Aug―19 Intermediates in SARS-CoV-2 spike-mediated cell entry Tara C. Marcink, Thomas Kicmal, Emily Armbruster, Zhening Zhang, Gillian Zipursky, Kate L. Golub, et al. (+8)
197 [GO] Science 2022―Aug―18 T cell immunity to COVID-19 vaccines E. John Wherry, Dan H. Barouch
198 [GO] Science 2022―Aug―18 Long Covid clues emerge from patients’ blood Jennifer Couzin-Frankel
199 [GO] Science Advances 2022―Aug―17 Complement C3 inhibition in severe COVID-19 using compstatin AMY-101 Panagiotis Skendros, Georgios Germanidis, Dimitrios C. Mastellos, Christina Antoniadou, Efstratios Gavriilidis, Georgios Kalopitas, et al. (+29)
200 [GO] Science Translational Medicine 2022―Aug―17 Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccine Prabhu S. Arunachalam, Yupeng Feng, Usama Ashraf, Mengyun Hu, Alexandra C. Walls, Venkata Viswanadh Edara, et al. (+39)
201 [GO] Science Immunology 2022―Aug―11 An Antibody from Single Human V H -rearranging Mouse Neutralizes All SARS-CoV-2 Variants Through BA.5 by Inhibiting Membrane Fusion Sai Luo, Jun Zhang, Alex J.B. Kreutzberger, Amanda Eaton, Robert J. Edwards, Changbin Jing, et al. (+24)
202 [GO] Science Immunology 2022―Aug―09 CD8 T Cells Contribute to Vaccine Protection Against SARS-CoV-2 in Macaques Jinyan Liu, Jingyou Yu, Katherine McMahan, Catherine Jacob-Dolan, Xuan He, Victoria Giffin, et al. (+19)
203 [GO] Science 2022―Aug―04 Making broader coronavirus vaccines is a struggle Jon Cohen
204 [GO] Science Immunology 2022―Aug―04 An antibody that neutralizes SARS-CoV-1 and SARS-CoV-2 by binding to a conserved spike epitope outside the receptor binding motif Yan Fang, Pengcheng Sun, Xuping Xie, Mingjian Du, Fenghe Du, Jianfeng Ye, et al. (+7)
205 [GO] Science Advances 2022―Aug―03 Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity Alberto Domingo López-Muñoz, Ivan Kosik, Jaroslav Holly, Jonathan W. Yewdell
206 [GO] Science Translational Medicine 2022―Jul―27 SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, Mary Wu, Ruth Harvey, Saira Hussain, et al. (+15)
207 [GO] Science 2022―Jul―26 The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic Michael Worobey, Joshua I. Levy, Lorena Malpica Serrano, Alexander Crits-Christoph, Jonathan E. Pekar, Stephen A. Goldstein, et al. (+12)
208 [GO] Science 2022―Jul―26 The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2 Jonathan E. Pekar, Andrew Magee, Edyth Parker, Niema Moshiri, Katherine Izhikevich, Jennifer L. Havens, et al. (+23)
209 [GO] Science Translational Medicine 2022―Jul―26 SARS-CoV-2 mRNA vaccination elicits robust antibody responses in children Yannic C Bartsch, Kerri J St Denis, Paulina Kaplonek, Jaewon Kang, Evan C Lam, Madeleine D Burns, et al. (+12)
210 [GO] Science Immunology 2022―Jul―21 Operation Nasal Vaccine-Lightning speed to counter COVID-19 Eric J. Topol, Akiko Iwasaki
211 [GO] Science Translational Medicine 2022―Jul―21 Elevated risk of infection with SARS-CoV-2 Beta, Gamma, and Delta variant compared to Alpha variant in vaccinated individuals Stijn P. Andeweg, Harry Vennema, Irene Veldhuijzen, Naomi Smorenburg, Dennis Schmitz, Florian Zwagemaker, et al. (+80)
212 [GO] Science Translational Medicine 2022―Jul―20 Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial Aaron M. Gusdon, Nauder Faraday, John S. Aita, Sunil Kumar, Ishan Mehta, HuiMahn A. Choi, et al. (+6)
213 [GO] Science Advances 2022―Jul―20 Tunneling nanotubes provide a route for SARS-CoV-2 spreading Anna Pepe, Stefano Pietropaoli, Matthijn Vos, Giovanna Barba-Spaeth, Chiara Zurzolo
214 [GO] Science Immunology 2022―Jul―19 Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination Jinyi Tang, Cong Zeng, Thomas M. Cox, Chaofan Li, Young Min Son, In Su Cheon, et al. (+21)
215 [GO] Science Advances 2022―Jul―15 Investigating trends in those who experience menstrual bleeding changes after SARS-CoV-2 vaccination Katharine M. N. Lee, Eleanor J. Junkins, Chongliang Luo, Urooba A. Fatima, Maria L. Cox, Kathryn B. H. Clancy
216 [GO] Science 2022―Jul―14 Nailing the nuance on COVID-19 Robert M. Wachter
217 [GO] Science 2022―Jul―14 Vaccinate to combat COVID-19 in China Ruishan Chen, Xiaona Guo, Annah Zhu
218 [GO] Science Immunology 2022―Jul―14 SARS-CoV-2-specific T cells in unexposed adults display broad trafficking potential and cross-react with commensal antigens Laurent Bartolo, Sumbul Afroz, Yi-Gen Pan, Ruozhang Xu, Lea Williams, Chin-Fang Lin, et al. (+6)
219 [GO] Science 2022―Jul―14 A treaty to break the pandemic cycle Alexandra L. Phelan, Colin J. Carlson
220 [GO] Science Advances 2022―Jul―13 Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities Yaozong Chen, Lulu Sun, Irfan Ullah, Guillaume Beaudoin-Bussières, Sai Priya Anand, Andrew P. Hederman, et al. (+17)
221 [GO] Science Translational Medicine 2022―Jul―12 A bivalent SARS-CoV-2 monoclonal antibody combination does not impact the immunogenicity of a vector-based COVID-19 vaccine in macaques Joseph P. Nkolola, Jingyou Yu, Huahua Wan, Aiquan Chang, Katherine McMahan, Tochi Anioke, et al. (+11)
222 [GO] Science 2022―Jul―12 ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici, Matthew McCallum, Dora Pinto, Antonino Cassotta, et al. (+27)
223 [GO] Science 2022―Jul―12 Broadly neutralizing antibodies target the coronavirus fusion peptide Cherrelle Dacon, Courtney Tucker, Linghang Peng, Chang-Chun D. Lee, Ting-Hui Lin, Meng Yuan, et al. (+38)
224 [GO] Science Translational Medicine 2022―Jul―07 SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, Hong Dang, Ethan J. Fritch, Kendra L. Gully, et al. (+39)
225 [GO] Science 2022―Jun―30 Pandemic-inspired policies Nandhini Kesavan, Senthilkumar Seenuvasaragavan, Katie Burnette, Ashley Barbara Heim, Rishi Jai Patel, Juliet Johnston, et al. (+7)
226 [GO] Science 2022―Jun―28 Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution Tyler N. Starr, Allison J. Greaney, William W. Hannon, Andrea N. Loes, Kevin Hauser, Josh R. Dillen, et al. (+9)
227 [GO] Science 2022―Jun―23 Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters Shuofeng Yuan, Zi-Wei Ye, Ronghui Liang, Kaiming Tang, Anna Jinxia Zhang, Gang Lu, et al. (+24)
228 [GO] Science Immunology 2022―Jun―23 Antigenic cartography of SARS-CoV-2 reveals that Omicron BA.1 and BA.2 are antigenically distinct Anna Z. Mykytyn, Melanie Rissmann, Adinda Kok, Miruna E. Rosu, Debby Schipper, Tim I. Breugem, et al. (+15)
229 [GO] Science Advances 2022―Jun―17 Lessons from SARS-CoV-2 in India: A data-driven framework for pandemic resilience Maxwell Salvatore, Soumik Purkayastha, Lakshmi Ganapathi, Rupam Bhattacharyya, Ritoban Kundu, Lauren Zimmermann, et al. (+6)
230 [GO] Science 2022―Jun―16 Clues to long COVID Jennifer Couzin-Frankel
231 [GO] Science 2022―Jun―16 Glacial pace for U.S. Long Covid grants Meredith Wadman
232 [GO] Science Immunology 2022―Jun―14 Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs Paul Bastard, Sara Vazquez, Jamin Liu, Matthew T. Laurie, Chung Yu Wang, Adrian Gervais, et al. (+375)
233 [GO] Science 2022―Jun―14 Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, Ashley D. Otter, Kai-Min Lin, Diana Muñoz Sandoval, et al. (+140)
234 [GO] Science Translational Medicine 2022―Jun―09 The anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, minimally impacts the endogenous immune response to COVID-19 vaccination Robert J. Benschop, Jay L. Tuttle, Lin Zhang, Josh Poorbaugh, Nicole L. Kallewaard, Peter Vaillancourt, et al. (+10)
235 [GO] Science Advances 2022―Jun―07 Neighborhood socioeconomic inequality based on everyday mobility predicts COVID-19 infection in San Francisco, Seattle, and Wisconsin Brian L. Levy, Karl Vachuska, S. V. Subramanian, Robert J. Sampson
236 [GO] Science Translational Medicine 2022―Jun―07 SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery Justin J. Frere, Randal A. Serafini, Kerri D. Pryce, Marianna Zazhytska, Kohei Oishi, Ilona Golynker, et al. (+16)
237 [GO] Science Advances 2022―Jun―03 Microfluidic particle dam for direct visualization of SARS-CoV-2 antibody levels in COVID-19 vaccinees Minghui Wu, Siying Wu, Gaobo Wang, Wengang Liu, Lok Ting Chu, Tianyi Jiang, et al. (+4)
238 [GO] Science Immunology 2022―Jun―02 Immune memory to SARS-CoV-2 Omicron BA.1 breakthrough infections: To change the vaccine or not? Menno C. van Zelm
239 [GO] Science Advances 2022―Jun―01 A systems biology approach identifies candidate drugs to reduce mortality in severely ill patients with COVID-19 Vinicius M. Fava, Mathieu Bourgey, Pubudu M. Nawarathna, Marianna Orlova, Pauline Cassart, Donald C. Vinh, et al. (+4)
240 [GO] Science Translational Medicine 2022―May―31 SARS-CoV-2 transmission, persistence of immunity, and estimates of Omicron’s impact in South African population cohorts Kaiyuan Sun, Stefano Tempia, Jackie Kleynhans, Anne von Gottberg, Meredith L McMorrow, Nicole Wolter, et al. (+15)
241 [GO] Science Advances 2022―May―27 The mechanisms of catalysis and ligand binding for the SARS-CoV-2 NSP3 macrodomain from neutron and x-ray diffraction at room temperature Galen J. Correy, Daniel W. Kneller, Gwyndalyn Phillips, Swati Pant, Silvia Russi, Aina E. Cohen, et al. (+9)
242 [GO] Science 2022―May―26 Coronavirus, adenovirus, or both? Hepatitis poses mystery Meredith Wadman
243 [GO] Science Advances 2022―May―25 Quantitative and ultrasensitive in situ immunoassay technology for SARS-CoV-2 detection in saliva Yuchao Chen, Fei Liu, Luke P. Lee
244 [GO] Science 2022―May―24 Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England Paul Elliott, Oliver Eales, Nicholas Steyn, David Tang, Barbara Bodinier, Haowei Wang, et al. (+14)
245 [GO] Science 2022―May―24 Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness Fritz Obermeyer, Martin Jankowiak, Nikolaos Barkas, Stephen F. Schaffner, Jesse D. Pyle, Leonid Yurkovetskiy, et al. (+7)
246 [GO] Science Immunology 2022―May―19 ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection Rajendra Karki, SangJoon Lee, Raghvendra Mall, Nagakannan Pandian, Yaqiu Wang, Bhesh Raj Sharma, et al. (+13)
247 [GO] Science Translational Medicine 2022―May―17 The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants Liu Cao, Yingjun Li, Sidi Yang, Guanguan Li, Qifan Zhou, Jing Sun, et al. (+34)
248 [GO] Science Translational Medicine 2022―May―17 Characterization of the SARS-CoV-2 B.1.621 (Mu) variant Peter J. Halfmann, Makoto Kuroda, Tammy Armbrust, James Theiler, Ariane Balaram, Gage K. Moreno, et al. (+24)
249 [GO] Science Advances 2022―May―13 Detecting anti-SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion Fernanda Ludolf, Fernanda F. Ramos, Flávia F. Bagno, João A. Oliveira-da-Silva, Thiago A. R. Reis, Myron Christodoulides, et al. (+5)
250 [GO] Science Immunology 2022―May―12 Immune recall improves antibody durability and breadth to SARS-CoV-2 variants Yuezhou Chen, Pei Tong, Noah Whiteman, Ali Sanjari Moghaddam, Mehrdad Zarghami, Adam Zuiani, et al. (+9)
251 [GO] Science 2022―May―12 Pandemic delays continue to plague polar science Paul Voosen
252 [GO] Science Immunology 2022―May―10 Antibodies induced by ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1 Ian W. Windsor, Pei Tong, Olivia Lavidor, Ali Sanjari Moghaddam, Lindsay G.A. McKay, Avneesh Gautam, et al. (+6)
253 [GO] Science 2022―May―05 Rapid response modeling of SARS-CoV-2 transmission Jon Zelner, Marisa Eisenberg
254 [GO] Science Translational Medicine 2022―May―05 Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model Stephanie N. Langel, Susan Johnson, Clarissa I. Martinez, Sarah N. Tedjakusuma, Nadine Peinovich, Emery G. Dora, et al. (+5)
255 [GO] Science Advances 2022―Apr―29 High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape Franz-Josef Obermair, Florian Renoux, Sebastian Heer, Chloe H. Lee, Nastassja Cereghetti, Marisa Loi, et al. (+9)
256 [GO] Science 2022―Apr―28 First self-copying mRNA vaccine proves itself in pandemic trial Jon Cohen
257 [GO] Science Translational Medicine 2022―Apr―28 Mutations in the SARS-CoV-2 RNA dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms Laura J. Stevens, Andrea J. Pruijssers, Hery W. Lee, Calvin J. Gordon, Egor P. Tchesnokov, Jennifer Gribble, et al. (+11)
258 [GO] Science Advances 2022―Apr―27 COVID-19 vaccine hesitancy in eight European countries: Prevalence, determinants, and heterogeneity Janina I. Steinert, Henrike Sternberg, Hannah Prince, Barbara Fasolo, Matteo M. Galizzi, Tim Büthe, Giuseppe A. Veltri
259 [GO] Science Translational Medicine 2022―Apr―26 An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo Nariko Ikemura, Shunta Taminishi, Tohru Inaba, Takao Arimori, Daisuke Motooka, Kazutaka Katoh, et al. (+12)
260 [GO] Science Immunology 2022―Apr―26 An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern Wenjuan Du, Daniel L. Hurdiss, Dubravka Drabek, Anna Z. Mykytyn, Franziska K. Kaiser, Mariana González-Hernández, et al. (+21)
261 [GO] Science Advances 2022―Apr―22 Novel quantification of regional fossil fuel CO 2 reductions during COVID-19 lockdowns using atmospheric oxygen measurements Penelope A. Pickers, Andrew C. Manning, Corinne Le Quéré, Grant L. Forster, Ingrid T. Luijkx, Christoph Gerbig, et al. (+2)
262 [GO] Science Immunology 2022―Apr―21 SARS-CoV-2 epitope-specific CD4 + memory T cell responses across COVID-19 disease severity and antibody durability Ryan W. Nelson, Yuezhou Chen, Olivia L. Venezia, Richard M Majerus, Daniel S. Shin, Mary N. Carrington, et al. (+112)
263 [GO] Science Advances 2022―Apr―20 In-person schooling and associated COVID-19 risk in the United States over spring semester 2021 Kirsten E. Wiens, Claire P. Smith, Elena Badillo-Goicoechea, Kyra H. Grantz, M. Kate Grabowski, Andrew S. Azman, et al. (+2)
264 [GO] Science Advances 2022―Apr―15 One-year surveillance of SARS-CoV-2 transmission of the ELISA cohort: A model for population-based monitoring of infection risk Christine Klein, Max Borsche, Alexander Balck, Bandik Föh, Johann Rahmöller, Elke Peters, et al. (+24)
265 [GO] Science Advances 2022―Apr―13 Time experience during social distancing: A longitudinal study during the first months of COVID-19 pandemic in Brazil André Mascioli Cravo, Gustavo Brito de Azevedo, Cristiano Moraes Bilacchi Azarias, Louise Catheryne Barne, Fernanda Dantas Bueno, Raphael Y. de Camargo, et al. (+5)
266 [GO] Science Translational Medicine 2022―Apr―12 Population-level implications of the Israeli booster campaign to curtail COVID-19 resurgence Nir Gavish, Rami Yaari, Amit Huppert, Guy Katriel
267 [GO] Science Signaling 2022―Apr―12 SARS-CoV-2 spike protein-induced cell fusion activates the cGAS-STING pathway and the interferon response Xiaoman Liu, Liang Wei, Fengwen Xu, Fei Zhao, Yu Huang, Zhangling Fan, et al. (+8)
268 [GO] Science Translational Medicine 2022―Apr―12 Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice Andrew C. Hunt, James Brett Case, Young-Jun Park, Longxing Cao, Kejia Wu, Alexandra C. Walls, et al. (+41)
269 [GO] Science Advances 2022―Apr―08 COVID-19 in low-tolerance border quarantine systems: Impact of the Delta variant of SARS-CoV-2 Cameron Zachreson, Freya M. Shearer, David J. Price, Michael J. Lydeamore, Jodie McVernon, James McCaw, Nicholas Geard
270 [GO] Science Translational Medicine 2022―Apr―05 SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum, but evades most convalescent serum and therapeutic antibodies Sabrina Lusvarghi, Simon D. Pollett, Sabari Nath Neerukonda, Wei Wang, Richard Wang, Russell Vassell, et al. (+24)
271 [GO] Science Immunology 2022―Mar―31 A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 delta infection Nanda Kishore Routhu, Sailaja Gangadhara, Lilin Lai, Meredith Elizabeth Davis Gardner, Katharine Floyd, Ayalnesh Shiferaw, et al. (+18)
272 [GO] Science Translational Medicine 2022―Mar―29 mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions Paulina Kaplonek, Deniz Cizmeci, Stephanie Fischinger, Ai-ris Collier, Todd Suscovich, Caitlyn Linde, et al. (+14)
273 [GO] Science Advances 2022―Mar―25 Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralizing SARS-CoV-2 nanobodies Leo Hanke, Daniel J. Sheward, Alec Pankow, Laura Perez Vidakovics, Vivien Karl, Changil Kim, et al. (+7)
274 [GO] Science Immunology 2022―Mar―24 Understanding T-cell responses to COVID-19 is essential for informing public health strategies Santosha Vardhana, Lance Baldo, William G. Morice, E. John Wherry
275 [GO] Science 2022―Mar―24 Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529 Tongqing Zhou, Lingshu Wang, John Misasi, Amarendra Pegu, Yi Zhang, Darcy R. Harris, et al. (+19)
276 [GO] Science Translational Medicine 2022―Mar―22 Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice Alexandra Schäfer, David R. Martinez, John J. Won, Rita M. Meganck, Fernando R. Moreira, Ariane J. Brown, et al. (+22)
277 [GO] Science Advances 2022―Mar―16 SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques Neil C. Dalvie, Lisa H. Tostanoski, Sergio A. Rodriguez-Aponte, Kawaljit Kaur, Sakshi Bajoria, Ozan S. Kumru, et al. (+34)
278 [GO] Science Translational Medicine 2022―Mar―15 Omicron variant Spike-specific antibody binding and Fc activity is preserved in recipients of mRNA or inactivated COVID-19 vaccines Yannic C. Bartsch, Xin Tong, Jaewon Kang, María José Avendaño, Eileen F. Serrano, Tamara García-Salum, et al. (+8)
279 [GO] Science 2022―Mar―15 Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa Juliet R. C. Pulliam, Cari van Schalkwyk, Nevashan Govender, Anne von Gottberg, Cheryl Cohen, Michelle J. Groome, et al. (+3)
280 [GO] Science 2022―Mar―10 The immunology and immunopathology of COVID-19 Miriam Merad, Catherine A. Blish, Federica Sallusto, Akiko Iwasaki
281 [GO] Science 2022―Mar―10 End COVID-19 in low- and middle-income countries Ahmed Mushfiq Mobarak, Edward Miguel, Jason Abaluck, Amrita Ahuja, Marcella Alsan, Abhijit Banerjee, et al. (+22)
282 [GO] Science 2022―Mar―10 COVID-19 vaccination: The road ahead Daniel M. Altmann, Rosemary J. Boyton
283 [GO] Science 2022―Mar―10 COVID-19-lessons for zoonotic disease Edward C. Holmes
284 [GO] Science 2022―Mar―10 Stopping pandemics before they start: Lessons learned from SARS-CoV-2 Aled M. Edwards, Ralph S. Baric, Erica Ollmann Saphire, Jeffrey B. Ulmer
285 [GO] Science 2022―Mar―10 The changing epidemiology of SARS-CoV-2 Katia Koelle, Michael A. Martin, Rustom Antia, Ben Lopman, Natalie E. Dean
286 [GO] Science Immunology 2022―Mar―10 Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues Christine E. Nelson, Sivaranjani Namasivayam, Taylor W. Foreman, Keith D. Kauffman, Shunsuke Sakai, Danielle E. Dorosky, et al. (+27)
287 [GO] Science 2022―Mar―10 A pandemic education Camila Fonseca Amorim da Silva, Anna Uzonyi, Joseph Michael Cusimano, Thomy Nilsson, Nikos Konstantinides, Fernanda Oda, et al. (+6)
288 [GO] Science 2022―Mar―10 When is a pandemic officially ‘over’? Meredith Wadman
289 [GO] Science 2022―Mar―08 KIR + CD8 + T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19 Jing Li, Maxim Zaslavsky, Yapeng Su, Jing Guo, Michael J. Sikora, Vincent van Unen, et al. (+30)
290 [GO] Science Translational Medicine 2022―Mar―08 Characterization of immune responses in fully vaccinated individuals following breakthrough infection with the SARS-CoV-2 delta variant Ai-ris Y. Collier, Catherine M. Brown, Katherine A. McMahan, Jingyou Yu, Jinyan Liu, Catherine Jacob-Dolan, et al. (+14)
291 [GO] Science 2022―Mar―03 Studies bolster pandemic origin in Wuhan animal market Jon Cohen
292 [GO] Science Advances 2022―Mar―02 Assets, stressors, and symptoms of persistent depression over the first year of the COVID-19 pandemic Catherine K. Ettman, Gregory H. Cohen, Salma M. Abdalla, Ludovic Trinquart, Brian C. Castrucci, Rachel H. Bork, et al. (+4)
293 [GO] Science Translational Medicine 2022―Mar―01 Vaccination with SARS-CoV-2 spike protein lacking glycan shields elicits enhanced protective responses in animal models Han-Yi Huang, Hsin-Yu Liao, Xiaorui Chen, Szu-Wen Wang, Cheng-Wei Cheng, Md. Shahed-Al-Mahmud, et al. (+23)
294 [GO] Science Advances 2022―Feb―25 Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces Laura C. Rosella, Ajay Agrawal, Joshua Gans, Avi Goldfarb, Sonia Sennik, Janice Stein
295 [GO] Science Advances 2022―Feb―25 The transmission game: Testing behavioral interventions in a pandemic-like simulation Jan K. Woike, Sebastian Hafenbrädl, Patricia Kanngiesser, Ralph Hertwig
296 [GO] Science 2022―Feb―24 Why do people die from COVID-19? Paul Bastard
297 [GO] Science 2022―Feb―24 Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen, Samantha K. Zepeda, John E. Bowen, Alexandra C. Walls, et al. (+11)
298 [GO] Science Advances 2022―Feb―23 Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses Long Chi Nguyen, Dongbo Yang, Vlad Nicolaescu, Thomas J. Best, Haley Gula, Divyasha Saxena, et al. (+26)
299 [GO] Science Translational Medicine 2022―Feb―23 Erratum for the Research Article: “First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes” by J. J. Guthmiller, J. Han, L. Li, A. W. Freyn, S. T. H. Liu, O. Stovicek, C. T. Stamper, H. L. Dugan, M. E. Tepora, H. A. Utset, D. J. Bitar, N. J. Hamel, S. Changrob, N.-Y. Zheng, M. Huang, F. Krammer, R. Nachbagauer, P. Palese, A. B. Ward, P. C. Wilson
300 [GO] Science Translational Medicine 2022―Feb―22 A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2-specific immune responses in rhesus macaques Xuan He, Malika Aid, Abishek Chandrashekar, Jingyou Yu, Katherine McMahan, Frank Wegmann, et al. (+21)
301 [GO] Science 2022―Feb―17 COVID-19 boosts risk of heart disease 1 year later Meredith Wadman
302 [GO] Science 2022―Feb―17 SARS-CoV-2 Beta variant infection elicits potent lineage-specific and cross-reactive antibodies S. Momsen Reincke, Meng Yuan, Hans-Christian Kornau, Victor M. Corman, Scott van Hoof, Elisa Sánchez-Sendin, et al. (+28)
303 [GO] Science Translational Medicine 2022―Feb―16 A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates M. Gordon Joyce, Hannah A. D. King, Ines Elakhal-Naouar, Aslaa Ahmed, Kristina K. Peachman, Camila Macedo Cincotta, et al. (+52)
304 [GO] Science Translational Medicine 2022―Feb―15 Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection John P. Evans, Cong Zeng, Claire Carlin, Gerard Lozanski, Linda J. Saif, Eugene M. Oltz, et al. (+2)
305 [GO] Science 2022―Feb―10 Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera Alexander Muik, Bonny Gaby Lui, Ann-Kathrin Wallisch, Maren Bacher, Julia Mühl, Jonas Reinholz, et al. (+11)
306 [GO] Science Translational Medicine 2022―Feb―09 Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity Catherine Riou, Roanne Keeton, Thandeka Moyo-Gwete, Tandile Hermanus, Prudence Kgagudi, Richard Baguma, et al. (+21)
307 [GO] Science Translational Medicine 2022―Feb―09 Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2-experienced individuals Marie I. Samanovic, Amber R. Cornelius, Sophie L. Gray-Gaillard, Joseph Richard Allen, Trishala Karmacharya, Jimmy P. Wilson, et al. (+5)
308 [GO] Science Translational Medicine 2022―Feb―08 A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection Panpan Zhou, Meng Yuan, Ge Song, Nathan Beutler, Namir Shaabani, Deli Huang, et al. (+17)
309 [GO] Science Immunology 2022―Feb―04 High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells Jennifer S. Chen, Ryan D. Chow, Eric Song, Tianyang Mao, Benjamin Israelow, Kathy Kamath, et al. (+17)
310 [GO] Science Advances 2022―Feb―04 The costs and benefits of primary prevention of zoonotic pandemics Aaron S. Bernstein, Amy W. Ando, Ted Loch-Temzelides, Mariana M. Vale, Binbin V. Li, Hongying Li, et al. (+14)
311 [GO] Science Immunology 2022―Feb―03 Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz, Anna Z. Mykytyn, Mart M Lamers, Susanne Bogers, et al. (+18)
312 [GO] Science Immunology 2022―Feb―03 SARS-CoV-2 Omicron-neutralizing memory B-cells are elicited by two doses of BNT162b2 mRNA vaccine Ryutaro Kotaki, Yu Adachi, Saya Moriyama, Taishi Onodera, Shuetsu Fukushi, Takaki Nagakura, et al. (+13)
313 [GO] Science Translational Medicine 2022―Feb―02 Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains Baoling Ying, Bradley Whitener, Laura A. VanBlargan, Ahmed O. Hassan, Swathi Shrihari, Chieh-Yu Liang, et al. (+14)
314 [GO] Science Translational Medicine 2022―Feb―01 Infection or a third dose of mRNA vaccine elicit neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients Xavier Charmetant, Maxime Espi, Ilies Benotmane, Véronique Barateau, Francoise Heibel, Fanny Buron, et al. (+17)
315 [GO] Science Immunology 2022―Jan―28 Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion Valeria Fumagalli, Micol Ravà, Davide Marotta, Pietro Di Lucia, Chiara Laura, Eleonora Sala, et al. (+16)
316 [GO] Science Advances 2022―Jan―28 Epidemiological characteristics of the B.1.526 SARS-CoV-2 variant Wan Yang, Sharon K. Greene, Eric R. Peterson, Wenhui Li, Robert Mathes, Laura Graf, et al. (+4)
317 [GO] Science 2022―Jan―27 Indirect protection of children from SARS-CoV-2 infection through parental vaccination Samah Hayek, Galit Shaham, Yatir Ben-Shlomo, Eldad Kepten, Noa Dagan, Daniel Nevo, et al. (+4)
318 [GO] Science 2022―Jan―27 Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel Ottavia Prunas, Joshua L. Warren, Forrest W. Crawford, Sivan Gazit, Tal Patalon, Daniel M. Weinberger, Virginia E. Pitzer
319 [GO] Science 2022―Jan―27 Vaccines may cause rare, Long Covid-like symptoms Jennifer Couzin-Frankel, Gretchen Vogel
320 [GO] Science Advances 2022―Jan―26 SARS-CoV-2 epidemic after social and economic reopening in three U.S. states reveals shifts in age structure and clinical characteristics Nathan B. Wikle, Thu Nguyen-Anh Tran, Bethany Gentilesco, Scott M. Leighow, Emmy Albert, Emily R. Strong, et al. (+10)
321 [GO] Science Translational Medicine 2022―Jan―26 An aluminum hydroxide:CpG adjuvant enhances protection elicited by a SARS-CoV-2 receptor binding domain vaccine in aged mice Etsuro Nanishi, Francesco Borriello, Timothy R. O’Meara, Marisa E. McGrath, Yoshine Saito, Robert E. Haupt, et al. (+40)
322 [GO] Science Immunology 2022―Jan―25 Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants Timothy A. Bates, Savannah K. McBride, Hans C. Leier, Gaelen Guzman, Zoe L. Lyski, Devin Schoen, et al. (+6)
323 [GO] Science Translational Medicine 2022―Jan―25 The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans Yueh-Ming Loo, Patrick M. McTamney, Rosalinda H. Arends, Michael E. Abram, Anastasia A. Aksyuk, Seme Diallo, et al. (+25)
324 [GO] Science 2022―Jan―21 Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain Katherine G. Nabel, Sarah A. Clark, Sundaresh Shankar, Junhua Pan, Lars E. Clark, Pan Yang, et al. (+25)
325 [GO] Science 2022―Jan―20 Nervous system consequences of COVID-19 Serena Spudich, Avindra Nath
326 [GO] Science 2022―Jan―20 Studies reveal dangers of SARS-CoV-2 infection in pregnancy Meredith Wadman
327 [GO] Science 2022―Jan―20 SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex Dhiraj Mannar, James W. Saville, Xing Zhu, Shanti S. Srivastava, Alison M. Berezuk, Katharine S. Tuttle, et al. (+3)
328 [GO] Science Advances 2022―Jan―19 Lack of practical identifiability may hamper reliable predictions in COVID-19 epidemic models Luca Gallo, Mattia Frasca, Vito Latora, Giovanni Russo
329 [GO] Science Advances 2022―Jan―19 Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B Jun Liu, Patrick Budylowski, Reuben Samson, Bryan D. Griffin, Giorgi Babuadze, Bhavisha Rathod, et al. (+21)
330 [GO] Science Advances 2022―Jan―19 The intrinsically disordered SARS-CoV-2 nucleoprotein in dynamic complex with its viral partner nsp3a Luiza Mamigonian Bessa, Serafima Guseva, Aldo R. Camacho-Zarco, Nicola Salvi, Damien Maurin, Laura Mariño Perez, et al. (+6)
331 [GO] Science Translational Medicine 2022―Jan―18 Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity Saborni Chakraborty, Joseph C. Gonzalez, Benjamin L. Sievers, Vamsee Mallajosyula, Srijoni Chakraborty, Megha Dubey, et al. (+36)
332 [GO] Science 2022―Jan―14 Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh Jason Abaluck, Laura H. Kwong, Ashley Styczynski, Ashraful Haque, Md. Alamgir Kabir, Ellen Bates-Jefferys, et al. (+16)
333 [GO] Science Translational Medicine 2022―Jan―14 Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses Benjamin L. Sievers, Saborni Chakraborty, Yong Xue, Terri Gelbart, Joseph C. Gonzalez, Arianna G. Cassidy, et al. (+16)
334 [GO] Science 2022―Jan―14 4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication Julien Sourimant, Carolin M. Lieber, Megha Aggarwal, Robert M. Cox, Josef D. Wolf, Jeong-Joong Yoon, et al. (+9)
335 [GO] Science 2022―Jan―14 Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants Catherine J. Reynolds, Joseph M. Gibbons, Corinna Pade, Kai-Min Lin, Diana Muñoz Sandoval, Franziska Pieper, et al. (+19)
336 [GO] Science 2022―Jan―14 India’s pandemic toll far exceeds official count Jon Cohen
337 [GO] Science Translational Medicine 2022―Jan―11 Predicting the mutational drivers of future SARS-CoV-2 variants of concern M. Cyrus Maher, Istvan Bartha, Steven Weaver, Julia di Iulio, Elena Ferri, Leah Soriaga, et al. (+10)
338 [GO] Science Advances 2022―Jan―07 Impact of close interpersonal contact on COVID-19 incidence: Evidence from 1 year of mobile device data Forrest W. Crawford, Sydney A. Jones, Matthew Cartter, Samantha G. Dean, Joshua L. Warren, Zehang Richard Li, et al. (+5)
339 [GO] Science Immunology 2022―Jan―07 Innate immunological pathways in COVID-19 pathogenesis Søren R. Paludan, Trine H. Mogensen
340 [GO] Science Advances 2022―Jan―07 Toward wide-spectrum antivirals against coronaviruses: Molecular characterization of SARS-CoV-2 NSP13 helicase inhibitors Gustavo R. Perez-Lemus, Cintia A. Menéndez, Walter Alvarado, Fabian Byléhn, Juan J. de Pablo
341 [GO] Science Advances 2022―Jan―07 A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection Naoko Iwata-Yoshikawa, Nozomi Shiwa, Tsuyoshi Sekizuka, Kaori Sano, Akira Ainai, Takuya Hemmi, et al. (+5)
342 [GO] Science Advances 2022―Jan―07 SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress Katharina M. Scherer, Luca Mascheroni, George W. Carnell, Lucia C. S. Wunderlich, Stanislaw Makarchuk, Marius Brockhoff, et al. (+10)
343 [GO] Science 2022―Jan―06 Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott, Youyi Fong, David Benkeser, Weiping Deng, et al. (+34)
344 [GO] Science 2022―Jan―06 The pandemic whistleblower Jon Cohen
345 [GO] Science Translational Medicine 2021―Dec―30 Inhaled remdesivir reduces viral burden in a nonhuman primate model of SARS-CoV-2 infection Meghan S. Vermillion, Eisuke Murakami, Bin Ma, Jared Pitts, Adrian Tomkinson, Davin Rautiola, et al. (+20)
346 [GO] Science Translational Medicine 2021―Dec―23 A Phase 2a clinical trial of Molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus William A. Fischer, Joseph J. Eron, Wayne Holman, Myron S. Cohen, Lei Fang, Laura J. Szewczyk, et al. (+13)
347 [GO] Science 2021―Dec―23 COVID-19 vaccine breakthrough infections Ravindra K. Gupta, Eric J. Topol
348 [GO] Science 2021―Dec―23 Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen, Laura E. Rosen, Ha V. Dang, et al. (+13)
349 [GO] Science 2021―Dec―23 A new tool to probe SARS-CoV-2 variants Bryan A. Johnson, Vineet D. Menachery
350 [GO] Science 2021―Dec―23 Rapid assessment of SARS-CoV-2-evolved variants using virus-like particles Abdullah M. Syed, Taha Y. Taha, Takako Tabata, Irene P. Chen, Alison Ciling, Mir M. Khalid, et al. (+6)
351 [GO] Science 2021―Dec―16 COVID-19 impact on infant and adolescent vaccine supplies Tania Cernuschi, Stefano Malvolti, Matthew Downham, Dominique Maugeais, David Robinson, Alejandro Cravioto
352 [GO] Science Advances 2021―Dec―15 Harmony COVID-19: A ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection Nuttada Panpradist, Enos C. Kline, Robert G. Atkinson, Michael Roller, Qin Wang, Ian T. Hull, et al. (+11)
353 [GO] Science 2021―Dec―09 How pandemic pressure is re-engineering clinical trials Jennifer Couzin-Frankel
354 [GO] Science Advances 2021―Dec―08 Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2 Kristen A. Rodrigues, Sergio A. Rodriguez-Aponte, Neil C. Dalvie, Jeong Hyun Lee, Wuhbet Abraham, Diane G. Carnathan, et al. (+16)
355 [GO] Science Advances 2021―Dec―08 TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection Yongjian Wu, Manni Wang, Huan Yin, Siqi Ming, Xingyu Li, Guanmin Jiang, et al. (+8)
356 [GO] Science Advances 2021―Dec―03 Rapid test to assess the escape of SARS-CoV-2 variants of concern Jacob T. Heggestad, Rhett J. Britton, David S. Kinnamon, Simone A. Wall, Daniel Y. Joh, Angus M. Hucknall, et al. (+11)
357 [GO] Science 2021―Dec―02 Dissecting the early COVID-19 cases in Wuhan Michael Worobey
358 [GO] Science Advances 2021―Dec―01 Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice Moustafa T. Mabrouk, Kevin Chiem, Edurne Rujas, Wei-Chiao Huang, Dushyant Jahagirdar, Breandan Quinn, et al. (+10)
359 [GO] Science Advances 2021―Dec―01 Live attenuated virus vaccine protects against SARS-CoV-2 variants of concern B.1.1.7 (Alpha) and B.1.351 (Beta) Jakob Trimpert, Julia M. Adler, Kathrin Eschke, Azza Abdelgawad, Theresa C. Firsching, Nadine Ebert, et al. (+5)
360 [GO] Science Advances 2021―Nov―26 Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality Elsa Brunet-Ratnasingham, Sai Priya Anand, Pierre Gantner, Alina Dyachenko, Gaël Moquin-Beaudry, Nathalie Brassard, et al. (+37)
361 [GO] Science Advances 2021―Nov―26 Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures Martina Zafferani, Christina Haddad, Le Luo, Jesse Davila-Calderon, Liang-Yuan Chiu, Christian Shema Mugisha, et al. (+10)
362 [GO] Science Translational Medicine 2021―Nov―24 Erratum for the Research Article: “Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses” by E. A. Bordt, L. L. Shook, C. Atyeo, K. M. Pullen, R. M. De Guzman, M.-C. Meinsohn, M. Chauvin, S. Fischinger, L. J. Yockey, K. James, R. Lima, L. M. Yonker, A. Fasano, S. Brigida, L. M. Bebell, D. J. Roberts, D. Pepin, J. R. Huh, S. D. Bilbo, J. Z. Li, A. Kaima, D. J. Schust, K. J. Gray, D. Lauffenburger, G. Alter, A. G. Edlow
363 [GO] Science 2021―Nov―18 Create a COVID-19 commission Christopher F. Chyba, Christine K. Cassel, Susan L. Graham, John P. Holdren, Ed Penhoet, William H. Press, et al. (+2)
364 [GO] Science 2021―Nov―18 COVID-19 vaccines for children Jeffrey S. Gerber, Paul A. Offit
365 [GO] Science 2021―Nov―11 Cash incentives, ethics, and COVID-19 vaccination Nancy S. Jecker
366 [GO] Science 2021―Nov―11 Antiviral pills could change pandemic’s course Jennifer Couzin-Frankel
367 [GO] Science Advances 2021―Nov―10 A regulatory T cell signature distinguishes the immune landscape of COVID-19 patients from those with other respiratory infections Sarah C. Vick, Marie Frutoso, Florian Mair, Andrew J. Konecny, Evan Greene, Caitlin R. Wolf, et al. (+8)
368 [GO] Science 2021―Nov―04 Children and COVID-19 in schools Shamez N. Ladhani
369 [GO] Science 2021―Nov―04 SARS-CoV-2 vaccine protection and deaths among US veterans during 2021 Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, Nickilou Y. Krigbaum, Arthur W. Wallace
370 [GO] Science Advances 2021―Nov―03 Regional impacts of COVID-19 on carbon dioxide detected worldwide from space Brad Weir, David Crisp, Christopher W. O’Dell, Sourish Basu, Abhishek Chatterjee, Jana Kolassa, et al. (+8)
371 [GO] Science 2021―Nov―02 An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19 Dafydd R. Owen, Charlotte M. N. Allerton, Annaliesa S. Anderson, Lisa Aschenbrenner, Melissa Avery, Simon Berritt, et al. (+37)
372 [GO] Science 2021―Nov―02 Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant Paul Elliott, David Haw, Haowei Wang, Oliver Eales, Caroline E. Walters, Kylie E. C. Ainslie, et al. (+584)
373 [GO] Science Immunology 2021―Nov―02 BNT162b2 vaccination induces durable SARS-CoV-2 specific T cells with a stem cell memory phenotype Gisella Guerrera, Mario Picozza, Silvia D’Orso, Roberta Placido, Marta Pirronello, Alice Verdiani, et al. (+10)
374 [GO] Science Advances 2021―Oct―29 Complete protection by a single-dose skin patch-delivered SARS-CoV-2 spike vaccine Christopher L. D. McMillan, Jovin J. Y. Choo, Adi Idris, Aroon Supramaniam, Naphak Modhiran, Alberto A. Amarilla, et al. (+14)
375 [GO] Science 2021―Oct―28 Defective viral RNA sensing linked to severe COVID-19 John Schoggins
376 [GO] Science 2021―Oct―28 Pandemic productivity dip may linger Jyoti Madhusoodanan
377 [GO] Science 2021―Oct―28 Pandemic spotlight brings attention-and plenty of heat Kai Kupferschmidt
378 [GO] Science 2021―Oct―28 Postpandemic adjustments
379 [GO] Science Translational Medicine 2021―Oct―27 Comment on “Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2” Michael A. Martin, Katia Koelle
380 [GO] Science Translational Medicine 2021―Oct―27 Response to comment on “Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2” Michael D. Nicholson, Lukas Endler, Alexandra Popa, Jakob-Wendelin Genger, Christoph Bock, Franziska Michor, Andreas Bergthaler
381 [GO] Science Translational Medicine 2021―Oct―26 Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort Raphael Carapito, Richard Li, Julie Helms, Christine Carapito, Sharvari Gujja, Véronique Rolli, et al. (+58)
382 [GO] Science Translational Medicine 2021―Oct―26 GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults Simone Lanini, Stefania Capone, Andrea Antinori, Stefano Milleri, Emanuele Nicastri, Roberto Camerini, et al. (+63)
383 [GO] Science 2021―Oct―26 Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant Jun Zhang, Tianshu Xiao, Yongfei Cai, Christy L. Lavine, Hanqin Peng, Haisun Zhu, et al. (+11)
384 [GO] Science Immunology 2021―Oct―26 Immune memory from SARS-CoV-2 infection in hamsters provides variant-independent protection but still allows virus transmission Shu Horiuchi, Kohei Oishi, Lucia Carrau, Justin Frere, Rasmus Møller, Maryline Panis, Benjamin R. tenOever
385 [GO] Science Advances 2021―Oct―23 Safe traveling in public transport amid COVID-19 Donggyun Ku, Chihyung Yeon, Seungjae Lee, Kyuhong Lee, Kiyeon Hwang, Yuen Chong Li, Sze Chun Wong
386 [GO] Science Advances 2021―Oct―23 Subtle differences in the pathogenicity of SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in rhesus macaques Vincent J. Munster, Meaghan Flagg, Manmeet Singh, Claude Kwe Yinda, Brandi N. Williamson, Friederike Feldmann, et al. (+14)
387 [GO] Science 2021―Oct―23 Control of Pandemic Influenza: Influenza . Virus, Vaccines, and Strategy. Proceedings of a meeting, Rougemont, Jan. 1976. Philip Selby, Ed. Published for Sandoz Institute for Health and Socio-Economic Studies by Academic Press, New York, 1976. 354 pp., illus. Paper, $19.75. Sandoz Institute Publication No. 5.; Influenza . The Viruses and the Disease. Charles H. Stuart-Harris and Geoffrey C. Schild. Publishing Sciences Group, Littleton, Mass., 1976. x, 242 pp., illus. $22. R. Walter Schlesinger
388 [GO] Science 2021―Oct―23 AIDS from Its Beginnings: History of AIDS . Emergence and Origin of a Modern Pandemic. Mirko D. Grmek. Princeton University Press, Princeton, NJ, 1990. xii, 279 pp. $29.95. Translated from the French edition (1989) by Russell C. Maulitz and Jacalyn Duffin. Elizabeth Fee
389 [GO] Science 2021―Oct―22 Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates Kizzmekia S. Corbett, Matthew Gagne, Danielle A. Wagner, Sarah O’ Connell, Sandeep R. Narpala, Dillon R. Flebbe, et al. (+60)
390 [GO] Science 2021―Oct―22 Tackling the pandemic with (biased) data Christina Pagel, Christian A. Yates
391 [GO] Science 2021―Oct―22 What tore apart The Lancet ’s COVID-19 origin probe? Jon Cohen
392 [GO] Science Translational Medicine 2021―Oct―21 Pregnancy Influences Immune Responses to SARS-CoV-2 Cristian Ovies, Eleanor C. Semmes, Carolyn B. Coyne
393 [GO] Science Translational Medicine 2021―Oct―21 COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and non-pregnant women Caroline Atyeo, Elizabeth A. DeRiso, Christine Davis, Evan A. Bordt, Rose M. De Guzman, Lydia L. Shook, et al. (+8)
394 [GO] Science Advances 2021―Oct―21 Mechanism of a COVID-19 nanoparticle vaccine candidate that elicits a broadly neutralizing antibody response to SARS-CoV-2 variants Yi-Nan Zhang, Jennifer Paynter, Cindy Sou, Tatiana Fourfouris, Ying Wang, Ciril Abraham, et al. (+4)
395 [GO] Science 2021―Oct―21 COVID-19 transmission dynamics underlying epidemic waves in Kenya Samuel P. C. Brand, John Ojal, Rabia Aziza, Vincent Were, Emelda A. Okiro, Ivy K Kombe, et al. (+27)
396 [GO] Science Translational Medicine 2021―Oct―21 Maternal SARS-CoV-2 infection elicits sexually dimorphic placental immune responses Evan A Bordt, Lydia L Shook, Caroline Atyeo, Krista M Pullen, Rose M De Guzman, Marie-Charlotte Meinsohn, et al. (+20)
397 [GO] Science Translational Medicine 2021―Oct―18 An affinity-enhanced, broadly neutralizing heavy chain-only antibody protects against SARS-CoV-2 infection in animal models Bert Schepens, Loes van Schie, Wim Nerinckx, Kenny Roose, Wander Van Breedam, Daria Fijalkowska, et al. (+57)
398 [GO] Science Immunology 2021―Oct―17 SARS-CoV-2 infection generates tissue-localized immunological memory in humans Maya M.L. Poon, Ksenia Rybkina, Yu Kato, Masaru Kubota, Rei Matsumoto, Nathaniel I. Bloom, et al. (+19)
399 [GO] Science 2021―Oct―16 Pandemic enters transition phase-but to what? Kai Kupferschmidt
400 [GO] Science Translational Medicine 2021―Oct―15 Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19 Felice D’Agnillo, Kathie-Anne Walters, Yongli Xiao, Zong-Mei Sheng, Kelsey Scherler, Jaekeun Park, et al. (+22)
401 [GO] Science 2021―Oct―15 mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern Rishi R. Goel, Mark M. Painter, Sokratis A. Apostolidis, Divij Mathew, Wenzhao Meng, Aaron M. Rosenfeld, et al. (+64)
402 [GO] Science 2021―Oct―15 Replication and single-cycle delivery of SARS-CoV-2 replicons Inna Ricardo-Lax, Joseph M. Luna, Tran Thi Nhu Thao, Jérémie Le Pen, Yingpu Yu, H.-Heinrich Hoffmann, et al. (+20)
403 [GO] Science 2021―Oct―15 Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India Mahesh S. Dhar, Robin Marwal, Radhakrishnan VS, Kalaiarasan Ponnusamy, Bani Jolly, Rahul C. Bhoyar, et al. (+73)
404 [GO] Science Immunology 2021―Oct―15 Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses Jared Feldman, Julia Bals, Clara G. Altomare, Kerri St. Denis, Evan C. Lam, Blake M. Hauser, et al. (+9)
405 [GO] Science 2021―Oct―15 With COVID-19, modeling takes on life and death importance Martin Enserink, Kai Kupferschmidt
406 [GO] Science Immunology 2021―Oct―14 Fractionating a COVID-19 Ad5-vectored vaccine improves virus-specific immunity Sarah Sanchez, Nicole Palacio, Tanushree Dangi, Thomas Ciucci, Pablo Penaloza-MacMaster
407 [GO] Science 2021―Oct―14 Can interferons stop COVID-19 before it takes hold? Meredith Wadman
408 [GO] Science Advances 2021―Oct―13 Transient lipid-bound states of spike protein heptad repeats provide insights into SARS-CoV-2 membrane fusion Sai Chaitanya Chiliveri, John M. Louis, Rodolfo Ghirlando, Ad Bax
409 [GO] Science Advances 2021―Oct―13 Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2-infected individuals reveal unlinked immune signatures Supriya Ravichandran, Gabrielle Grubbs, Juanjie Tang, Youri Lee, Chang Huang, Hana Golding, Surender Khurana
410 [GO] Science Advances 2021―Oct―13 Low case numbers enable long-term stable pandemic control without lockdowns Sebastian Contreras, Jonas Dehning, Sebastian B. Mohr, Simon Bauer, F. Paul Spitzner, Viola Priesemann
411 [GO] Science 2021―Oct―12 Monetary incentives increase COVID-19 vaccinations Pol Campos-Mercade, Armando N. Meier, Florian H. Schneider, Stephan Meier, Devin Pope, Erik Wengström
412 [GO] Science 2021―Oct―10 A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa Eduan Wilkinson, Marta Giovanetti, Houriiyah Tegally, James E. San, Richard Lessells, Diego Cuadros, et al. (+296)
413 [GO] Science 2021―Oct―10 Pandemic haiku Jennifer Sills
414 [GO] Science Immunology 2021―Sep―30 Immune signatures underlying post-acute COVID-19 lung sequelae IS Cheon, C Li, YM Son, NP Goplen, Y Wu, T Cassmann, et al. (+24)
415 [GO] Science Translational Medicine 2021―Sep―30 Early sample tagging and pooling enables simultaneous SARS-CoV-2 detection and variant sequencing Alon Chappleboim, Daphna Joseph-Strauss, Ayelet Rahat, Israa Sharkia, Miriam Adam, Daniel Kitsberg, et al. (+11)
416 [GO] Science Translational Medicine 2021―Sep―30 AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire Phillip A. Swanson, Marcelino Padilla, Wesley Hoyland, Kelly McGlinchey, Paul A. Fields, Sagida Bibi, et al. (+63)
417 [GO] Science Advances 2021―Sep―29 Geographically targeted COVID-19 vaccination is more equitable and averts more deaths than age-based thresholds alone Elizabeth Wrigley-Field, Mathew V. Kiang, Alicia R. Riley, Magali Barbieri, Yea-Hung Chen, Kate A. Duchowny, et al. (+5)
418 [GO] Science 2021―Sep―28 A prenylated dsRNA sensor protects against severe COVID-19 Arthur Wickenhagen, Elena Sugrue, Spyros Lytras, Srikeerthana Kuchi, Marko Noerenberg, Matthew L. Turnbull, et al. (+416)
419 [GO] Science 2021―Sep―23 Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study Kathryn M. Hastie, Haoyang Li, Daniel Bedinger, Sharon L. Schendel, S. Moses Dennison, Kan Li, et al. (+67)
420 [GO] Science 2021―Sep―23 Large study will probe Long Covid Jocelyn Kaiser
421 [GO] Science Advances 2021―Sep―22 Reduced human activity during COVID-19 alters avian land use across North America Michael B. Schrimpf, Paulson G. Des Brisay, Alison Johnston, Adam C. Smith, Jessica Sánchez-Jasso, Barry G. Robinson, et al. (+6)
422 [GO] Science Advances 2021―Sep―22 Social media conversations reveal large psychological shifts caused by COVID-19’s onset across U.S. cities Ashwini Ashokkumar, James W. Pennebaker
423 [GO] Science Advances 2021―Sep―22 Direct detection of human adenovirus or SARS-CoV-2 with ability to inform infectivity using DNA aptamer-nanopore sensors Ana S. Peinetti, Ryan J. Lake, Wen Cong, Laura Cooper, Yuting Wu, Yuan Ma, et al. (+7)
424 [GO] Science Translational Medicine 2021―Sep―21 Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against re-infection with B.1.1.7 and B.1.351 variants Abishek Chandrashekar, Jinyan Liu, Jingyou Yu, Katherine McMahan, Lisa H. Tostanoski, Catherine Jacob-Dolan, et al. (+26)
425 [GO] Science Immunology 2021―Sep―17 Of bats and men: Immunomodulatory treatment options for COVID-19 guided by the immunopathology of SARS-CoV-2 infection Michael J. Christie, Aaron T. Irving, Samuel C. Forster, Benjamin J. Marsland, Philip M. Hansbro, Paul J. Hertzog, et al. (+2)
426 [GO] Science 2021―Sep―16 Institutions’ role in postpandemic support Antoine de Morree, Al’ai Alvarez
427 [GO] Science Advances 2021―Sep―15 Ultrafast, sensitive, and portable detection of COVID-19 IgG using flexible organic electrochemical transistors Hong Liu, Anneng Yang, Jiajun Song, Naixiang Wang, Puiyiu Lam, Yuenling Li, et al. (+2)
428 [GO] Science Translational Medicine 2021―Sep―15 What have we learned from the COVID-19 plague? Stanley A. Plotkin
429 [GO] Science 2021―Sep―14 Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells Jose Mateus, Jennifer M. Dan, Zeli Zhang, Carolyn Rydyznski Moderbacher, Marshall Lammers, Benjamin Goodwin, et al. (+3)
430 [GO] Science Immunology 2021―Sep―14 Identification of resident memory CD8 + T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue Julia Niessl, Takuya Sekine, Joshua Lange, Viktoria Konya, Marianne Forkel, Jovana Maric, et al. (+13)
431 [GO] Science Translational Medicine 2021―Sep―14 Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern Hyeseon Cho, Kristina Kay Gonzales-Wartz, Deli Huang, Meng Yuan, Mary Peterson, Janie Liang, et al. (+34)
432 [GO] Science Advances 2021―Sep―10 Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques Kevin R. Bewley, Karen Gooch, Kelly M. Thomas, Stephanie Longet, Nathan Wiblin, Laura Hunter, et al. (+36)
433 [GO] Science Immunology 2021―Sep―09 Early cross-coronavirus reactive signatures of humoral immunity against COVID-19 Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, Stephanie Fischinger, Matthew J. Gorman, Kathryn Bowman, et al. (+36)
434 [GO] Science 2021―Sep―09 A COVID-19 publishing revolution? Not yet Jeffrey Brainard
435 [GO] Science 2021―Sep―09 U.S. ups coronavirus surveillance Meredith Wadman
436 [GO] Science 2021―Sep―09 A pandemic prevention moonshot Jon Cohen
437 [GO] Science Advances 2021―Sep―08 Platelets amplify endotheliopathy in COVID-19 Tessa J. Barrett, MacIntosh Cornwell, Khrystyna Myndzar, Christina C. Rolling, Yuhe Xia, Kamelia Drenkova, et al. (+18)
438 [GO] Science Advances 2021―Sep―08 A universal bacteriophage T4 nanoparticle platform to design multiplex SARS-CoV-2 vaccine candidates by CRISPR engineering Jingen Zhu, Neeti Ananthaswamy, Swati Jain, Himanshu Batra, Wei-Chun Tang, Douglass A. Lewry, et al. (+8)
439 [GO] Science Translational Medicine 2021―Sep―07 Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern Lisa H. Tostanoski, Jingyou Yu, Noe B. Mercado, Katherine McMahan, Catherine Jacob-Dolan, Amanda J. Martinot, et al. (+24)
440 [GO] Science Advances 2021―Sep―03 Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination Tom G. Caniels, Ilja Bontjer, Karlijn van der Straten, Meliawati Poniman, Judith A. Burger, Brent Appelman, et al. (+22)
441 [GO] Science Immunology 2021―Sep―02 Adaptive immune determinants of viral clearance and protection in mouse models of SARS-CoV-2 Benjamin Israelow, Tianyang Mao, Jonathan Klein, Eric Song, Bridget Menasche, Saad B. Omer, Akiko Iwasaki
442 [GO] Science 2021―Sep―02 SARS-CoV-2 infection confers greater immunity than shots Meredith Wadman
443 [GO] Science 2021―Sep―02 The hunt for SARS-CoV-2’s ancestors heats up Jon Cohen
444 [GO] Science 2021―Aug―31 Cross-reactive CD4+ T cells enhance SARS-CoV-2 immune responses upon infection and vaccination Lucie Loyal, Julian Braun, Larissa Henze, Beate Kruse, Manuela Dingeldey, Ulf Reimer, et al. (+31)
445 [GO] Science 2021―Aug―26 The case for wildlife as the COVID-19 origin Gemma Alderton, Michael Funk
446 [GO] Science Advances 2021―Aug―25 Rapid greening response of China’s 2020 spring vegetation to COVID-19 restrictions: Implications for climate change Fenzhen Su, Dongjie Fu, Fengqin Yan, Han Xiao, Tingting Pan, Yang Xiao, et al. (+8)
447 [GO] Science Translational Medicine 2021―Aug―24 Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19 Monique G.P. van der Wijst, Sara E. Vazquez, George C. Hartoularos, Paul Bastard, Tianna Grant, Raymund Bueno, et al. (+39)
448 [GO] Science Immunology 2021―Aug―19 X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 Takaki Asano, Bertrand Boisson, Fanny Onodi, Daniela Matuozzo, Marcela Moncada-Velez, Majistor Raj Luxman Maglorius Renkilaraj, et al. (+101)
449 [GO] Science Immunology 2021―Aug―19 Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Paul Bastard, Adrian Gervais, Tom Le Voyer, Jérémie Rosain, Quentin Philippot, Jérémy Manry, et al. (+175)
450 [GO] Science 2021―Aug―19 Targeting the main protease of SARS-CoV-2 Valda Vinson, Stella Hurtley
451 [GO] Science 2021―Aug―19 Poultry passport to pandemic Caroline Ash, Stella Hurtley
452 [GO] Science Advances 2021―Aug―18 Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity Zintis Inde, Ben A. Croker, Clarence Yapp, Gaurav N. Joshi, Johan Spetz, Cameron Fraser, et al. (+25)
453 [GO] Science Advances 2021―Aug―18 Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection Nader Yatim, Jeremy Boussier, Pauline Tetu, Nikaïa Smith, Timothée Bruel, Bruno Charbit, et al. (+23)
454 [GO] Science 2021―Aug―17 Vaccine nationalism and the dynamics and control of SARS-CoV-2 Caroline E. Wagner, Chadi M. Saad-Roy, Sinead E. Morris, Rachel E. Baker, Michael J. Mina, Jeremy Farrar, et al. (+7)
455 [GO] Science 2021―Aug―17 The animal origin of SARS-CoV-2 Spyros Lytras, Wei Xia, Joseph Hughes, Xiaowei Jiang, David L. Robertson
456 [GO] Science Advances 2021―Aug―13 Excess of COVID-19 cases and deaths due to fine particulate matter exposure during the 2020 wildfires in the United States Xiaodan Zhou, Kevin Josey, Leila Kamareddine, Miah C. Caine, Tianjia Liu, Loretta J. Mickley, et al. (+2)
457 [GO] Science 2021―Aug―12 Defenses against SARS-CoV-2 variants Valda Vinson, Stella Hurtley
458 [GO] Science 2021―Aug―12 Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants Amarendra Pegu, Sarah O’Connell, Stephen D. Schmidt, Sijy O’Dell, Chloe A. Talana, Lilin Lai, et al. (+26)
459 [GO] Science Advances 2021―Aug―11 Cell therapy strategies for COVID-19: Current approaches and potential applications Mark M. Zaki, Emal Lesha, Khaled Said, Kiavash Kiaee, Lindsey Robinson-McCarthy, Haydy George, et al. (+6)
460 [GO] Science Advances 2021―Aug―11 A general model for the demographic signatures of the transition from pandemic emergence to endemicity Ruiyun Li, C. Jessica E. Metcalf, Nils Chr. Stenseth, Ottar N. Bjørnstad
461 [GO] Science Immunology 2021―Aug―10 Immunophenotyping assessment in a COVID-19 cohort (IMPACC): A prospective longitudinal study
462 [GO] Science Immunology 2021―Aug―10 Integrated longitudinal immunophenotypic, transcriptional and repertoire analyses delineate immune responses in COVID-19 patients Samuele Notarbartolo, Valeria Ranzani, Alessandra Bandera, Paola Gruarin, Valeria Bevilacqua, Anna Rita Putignano, et al. (+31)
463 [GO] Science Translational Medicine 2021―Aug―10 Two doses of the SARS-CoV-2 BNT162b2 vaccine enhances antibody responses to variants in individuals with prior SARS-CoV-2 infection Richard A Urbanowicz, Theocharis Tsoleridis, Hannah J Jackson, Lola Cusin, Joshua D Duncan, Joseph G Chappell, et al. (+13)
464 [GO] Science Advances 2021―Aug―06 Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants Helena de Puig, Rose A. Lee, Devora Najjar, Xiao Tan, Luis R. Soekensen, Nicolaas M. Angenent-Mari, et al. (+11)
465 [GO] Science 2021―Aug―05 SARS-CoV-2 from alpha to epsilon Valda Vinson, Michael Funk
466 [GO] Science 2021―Aug―05 Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity Sophie M.-C. Gobeil, Katarzyna Janowska, Shana McDowell, Katayoun Mansouri, Robert Parks, Victoria Stalls, et al. (+10)
467 [GO] Science Advances 2021―Jul―30 SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay Michael J. Peluso, Saki Takahashi, Jill Hakim, J. Daniel Kelly, Leonel Torres, Nikita S. Iyer, et al. (+40)
468 [GO] Science Immunology 2021―Jul―29 Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers Shelley Klompus, Sigal Leviatan, Thomas Vogl, Roei D. Mazor, Iris N. Kalka, Liat Stoler-Barak, et al. (+14)
469 [GO] Science 2021―Jul―29 Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates Kizzmekia S. Corbett, Martha C. Nason, Britta Flach, Matthew Gagne, Sarah O’Connell, Timothy S. Johnston, et al. (+58)
470 [GO] Science 2021―Jul―29 No shortcuts to SARS-CoV-2 antivirals Aled Edwards, Ingo V. Hartung
471 [GO] Science 2021―Jul―29 The Long Covid pandemic Gemma Alderton, Michael Funk
472 [GO] Science 2021―Jul―29 The road to addressing Long Covid Nisreen A. Alwan
473 [GO] Science Advances 2021―Jul―28 Interdependent program evaluation: Geographic and social spillovers in COVID-19 closures and reopenings in the United States Michael Zhao, David Holtz, Sinan Aral
474 [GO] Science Translational Medicine 2021―Jul―27 Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models Neeltje van Doremalen, Jyothi N. Purushotham, Jonathan E. Schulz, Myndi G. Holbrook, Trenton Bushmaker, Aaron Carmody, et al. (+15)
475 [GO] Science 2021―Jul―27 Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme Chang Liu, Wei Shi, Scott T. Becker, David G. Schatz, Bin Liu, Yang Yang
476 [GO] Science Translational Medicine 2021―Jul―27 Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates Joseph R. Francica, Barbara J. Flynn, Kathryn E. Foulds, Amy T. Noe, Anne P. Werner, Ian N. Moore, et al. (+54)
477 [GO] Science 2021―Jul―22 Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence Moritz U.G. Kraemer, Verity Hill, Christopher Ruis, Simon Dellicour, Sumali Bajaj, John T. McCrone, et al. (+18)
478 [GO] Science 2021―Jul―22 WHO chief pressures China on pandemic origin Jon Cohen
479 [GO] Science 2021―Jul―20 Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 Nir Drayman, Jennifer K. DeMarco, Krysten A. Jones, Saara-Anne Azizi, Heather M. Froggatt, Kemin Tan, et al. (+32)
480 [GO] Science Translational Medicine 2021―Jul―20 A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters Yangtao Wu, Xiaofen Huang, Lunzhi Yuan, Shaojuan Wang, Yali Zhang, Hualong Xiong, et al. (+30)
481 [GO] Science Immunology 2021―Jul―15 A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates Maria Pino, Talha Abid, Susan Pereira Ribeiro, Venkata Viswanadh Edara, Katharine Floyd, Justin C. Smith, et al. (+41)
482 [GO] Science 2021―Jul―15 Senescent cells exacerbate COVID-19 Valda Vinson, Michael Funk
483 [GO] Science 2021―Jul―15 Added value of PCR testing for COVID-19 Caroline Ash, Michael Funk
484 [GO] Science 2021―Jul―15 Will COVID-19 change science? Past pandemics offer clues Jennifer Couzin-Frankel
485 [GO] Science Advances 2021―Jul―14 Meaningful messaging: Sentiment in elite social media communication with the public on the COVID-19 pandemic Janet M. Box-Steffensmeier, Laura Moses
486 [GO] Science Translational Medicine 2021―Jul―13 A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma Craig Fenwick, Priscilla Turelli, Céline Pellaton, Alex Farina, Jérémy Campos, Charlène Raclot, et al. (+8)
487 [GO] Science Immunology 2021―Jul―09 Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in patients with COVID-19 Baweleta Isho, Kento T. Abe, Michelle Zuo, Alainna J. Jamal, Bhavisha Rathod, Jenny H. Wang, et al. (+30)
488 [GO] Science 2021―Jul―09 Sex-specific metabolism and COVID-19 John F. Foley, Michael Funk
489 [GO] Science 2021―Jul―09 Sex and gender missing in COVID-19 data Cathleen O'Grady
490 [GO] Science 2021―Jul―09 Journal retracts paper claiming COVID-19 vaccines kill Meredith Wadman
491 [GO] Science 2021―Jul―09 Networks of SARS-CoV-2 transmission Muge Cevik, Stefan D. Baral
492 [GO] Science 2021―Jul―08 ‘Too good to be true’: Doubts swirl around trial that saw 77% reduction in COVID-19 mortality Robert Service
493 [GO] Science 2021―Jul―07 COVID-19 affects men and women differently. So why don’t clinical trials report gender data? Cathleen O’Grady
494 [GO] Science 2021―Jul―07 Why the COVID-19 pandemic could lead to overdue change in academia June Gruber
495 [GO] Science Translational Medicine 2021―Jul―07 Increasing threats from SARS-CoV-2 variants: Time to establish global surveillance Scott P. Layne, Jeffery K. Taubenberger
496 [GO] Science Signaling 2021―Jul―06 Kynurenic acid may underlie sex-specific immune responses to COVID-19 Yuping Cai, Daniel J. Kim, Takehiro Takahashi, David I. Broadhurst, Hong Yan, Shuangge Ma, et al. (+15)
497 [GO] Science Signaling 2021―Jul―06 Long-chain polyphosphates impair SARS-CoV-2 infection and replication Veronica Ferrucci, Dae-Young Kong, Fatemeh Asadzadeh, Laura Marrone, Angelo Boccia, Roberto Siciliano, et al. (+29)
498 [GO] Science 2021―Jul―03 Scientists quit journal board, protesting ‘grossly irresponsible’ study claiming COVID-19 vaccines kill Meredith Wadman
499 [GO] Science 2021―Jul―03 Can immune responses alone reveal which COVID-19 vaccines work best? Jon Cohen
500 [GO] Science Advances 2021―Jul―02 Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine Dong An, Kun Li, Dawne K. Rowe, Maria Cristina Huertas Diaz, Emily F. Griffin, Ashley C. Beavis, et al. (+14)
501 [GO] Science 2021―Jul―01 Did a Chinese team ‘obscure’ early coronavirus sequences? Jon Cohen
502 [GO] Science 2021―Jul―01 Pandemic haiku
503 [GO] Science Immunology 2021―Jul―01 CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in COVID-19 patients Vamsee Mallajosyula, Conner Ganjavi, Saborni Chakraborty, Alana M. McSween, Ana Jimena Pavlovitch-Bedzyk, Julie Wilhelmy, et al. (+4)
504 [GO] Science 2021―Jul―01 SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern Matthew McCallum, Jessica Bassi, Anna De Marco, Alex Chen, Alexandra C. Walls, Julia Di Iulio, et al. (+26)
505 [GO] Science Immunology 2021―Jul―01 Implications of defective immune responses in SARS-CoV-2 vaccinated organ transplant recipients Peter S. Heeger, Christian P. Larsen, Dorry L. Segev
506 [GO] Science 2021―Jul―01 Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants Lingshu Wang, Tongqing Zhou, Yi Zhang, Eun Sung Yang, Chaim A. Schramm, Wei Shi, et al. (+52)
507 [GO] Science Advances 2021―Jun―30 Identification of SARS-CoV-2-induced pathways reveals drug repurposing strategies Namshik Han, Woochang Hwang, Konstantinos Tzelepis, Patrick Schmerer, Eliza Yankova, Méabh MacMahon, et al. (+10)
508 [GO] Science Signaling 2021―Jun―29 Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16 George Minasov, Monica Rosas-Lemus, Ludmilla Shuvalova, Nicole L. Inniss, Joseph S. Brunzelle, Courtney M. Daczkowski, et al. (+3)
509 [GO] Science 2021―Jun―25 Delta variant triggers new phase in the pandemic Kai Kupferschmidt, Meredith Wadman
510 [GO] Science Advances 2021―Jun―25 Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test Jacob T. Heggestad, David S. Kinnamon, Lyra B. Olson, Jason Liu, Garrett Kelly, Simone A. Wall, et al. (+18)
511 [GO] Science 2021―Jun―24 Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants Yongfei Cai, Jun Zhang, Tianshu Xiao, Christy L. Lavine, Shaun Rawson, Hanqin Peng, et al. (+13)
512 [GO] Science Advances 2021―Jun―23 Effects of COVID-19 lockdowns on fine particulate matter concentrations Melanie S. Hammer, Aaron van Donkelaar, Randall V. Martin, Erin E. McDuffie, Alexei Lyapustin, Andrew M. Sayer, et al. (+5)
513 [GO] Science Translational Medicine 2021―Jun―22 Undiagnosed SARS-CoV-2 Seropositivity During the First Six Months of the COVID-19 Pandemic in the United States Heather Kalish, Carleen Klumpp-Thomas, Sally Hunsberger, Holly Ann Baus, Michael P Fay, Nalyn Siripong, et al. (+47)
514 [GO] Science Immunology 2021―Jun―22 COVID-19 vaccine side effects: The positives about feeling bad Jonathan Sprent, Cecile King
515 [GO] Science 2021―Jun―22 Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer, Audrey Fischer, Matthew J. O’Meara, Blandine Monel, et al. (+23)
516 [GO] Science Translational Medicine 2021―Jun―22 Key epidemiological drivers and impact of interventions in the 2020 SARS-CoV-2 epidemic in England Edward S. Knock, Lilith K. Whittles, John A. Lees, Pablo N. Perez-Guzman, Robert Verity, Richard G. FitzJohn, et al. (+25)
517 [GO] Science 2021―Jun―17 Probing CD4 T cell immunity to SARS-CoV-2 Seth Thomas Scanlon, Michael Funk
518 [GO] Science Advances 2021―Jun―16 Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity Hin Chu, Huiping Shuai, Yuxin Hou, Xi Zhang, Lei Wen, Xiner Huang, et al. (+19)
519 [GO] Science Translational Medicine 2021―Jun―15 Serum neurofilament light protein correlates with unfavorable clinical outcomes in hospitalized patients with COVID-19 Mercedes Prudencio, Young Erben, Christopher P. Marquez, Karen R. Jansen-West, Camila Franco-Mesa, Michael G. Heckman, et al. (+15)
520 [GO] Science Immunology 2021―Jun―15 Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients Hector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski, Fabian Halleck, Ulrike Weber, Franziska Szelinski, et al. (+19)
521 [GO] Science Immunology 2021―Jun―15 SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques Carolina Garrido, Alan D. Curtis, Maria Dennis, Sachi H. Pathak, Hongmei Gao, David Montefiori, et al. (+19)
522 [GO] Science 2021―Jun―10 Japanese scientists warn that Tokyo Olympics could help spread COVID-19 Dennis Normile
523 [GO] Science 2021―Jun―10 Brazil gives Russian COVID-19 vaccine a chance, approving the import of limited doses Sofia Moutinho
524 [GO] Science 2021―Jun―10 Mixing COVID-19 vaccines appears to boost immune responses Gretchen Vogel
525 [GO] Science 2021―Jun―10 DNA test to predict odds of severe COVID-19 draws scrutiny Jocelyn Kaiser
526 [GO] Science 2021―Jun―10 Atmospheric ozone and pandemic lockdowns Jonathan P. D. Abbatt, Michael Funk
527 [GO] Science Advances 2021―Jun―09 Global tropospheric ozone responses to reduced NOx emissions linked to the COVID-19 worldwide lockdowns Kazuyuki Miyazaki, Kevin Bowman, Takashi Sekiya, Masayuki Takigawa, Jessica L. Neu, Kengo Sudo, et al. (+2)
528 [GO] Science 2021―Jun―08 A ‘landmark’ trial to test mRNA vaccines against COVID-19 in Africa can’t get the coveted shots Jon Cohen
529 [GO] Science 2021―Jun―08 Would you have your DNA tested to predict how hard COVID-19 would strike? Should you? Jocelyn Kaiser
530 [GO] Science Translational Medicine 2021―Jun―08 Plasma from patients with bacterial sepsis or severe COVID-19 induces production of suppressive myeloid cells from human hematopoietic progenitor cells in vitro Miguel Reyes, Michael R. Filbin, Roby P. Bhattacharyya, Abraham Sonny, Arnav Mehta, Kianna Billman, et al. (+12)
531 [GO] Science 2021―Jun―08 Senolytics reduce coronavirus-related mortality in old mice Christina D. Camell, Matthew J. Yousefzadeh, Yi Zhu, Larissa G. P. Langhi Prata, Matthew A. Huggins, Mark Pierson, et al. (+28)
532 [GO] Science Translational Medicine 2021―Jun―08 Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection Allison J. Greaney, Andrea N. Loes, Lauren E. Gentles, Katharine H.D. Crawford, Tyler N. Starr, Keara D. Malone, et al. (+2)
533 [GO] Science 2021―Jun―05 Tragic spring surge leads India to crank up coronavirus vaccine effort Joel Goldberg
534 [GO] Science Immunology 2021―Jun―04 Anti-body antibodies in COVID-19 Andrew H. Lichtman
535 [GO] Science 2021―Jun―03 Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets Nunziata Maio, Bernard A. P. Lafont, Debangsu Sil, Yan Li, J. Martin Bollinger, Carsten Krebs, et al. (+3)
536 [GO] Science 2021―Jun―03 Respiratory viruses during the pandemic Gemma Alderton, Michael Funk
537 [GO] Science 2021―Jun―03 Uncertain effects of the pandemic on respiratory viruses Gabriela B. Gomez, Cedric Mahé, Sandra S. Chaves
538 [GO] Science 2021―Jun―02 Brazilian town experiment shows mass vaccination can wipe out COVID-19 Sofia Moutinho
539 [GO] Science 2021―Jun―02 Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men Gretchen Vogel
540 [GO] Science Translational Medicine 2021―Jun―02 First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes Jenna J. Guthmiller, Julianna Han, Lei Li, Alec W. Freyn, Sean T. H. Liu, Olivia Stovicek, et al. (+14)
541 [GO] Science 2021―May―28 Scientists rally around misconduct consultant facing legal threat after challenging COVID-19 drug researcher Cathleen O’Grady
542 [GO] Science 2021―May―28 ‘Dear those in charge’: A scientist’s coronavirus impact statement Adam Ruben
543 [GO] Science Advances 2021―May―28 Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates So-Hee Hong, Hanseul Oh, Yong Wook Park, Hye Won Kwak, Eun Young Oh, Hyo-Jung Park, et al. (+30)
544 [GO] Science 2021―May―27 Rich countries cornered COVID-19 vaccine doses. Four strategies to right a ‘scandalous inequity’ Jon Cohen
545 [GO] Science 2021―May―27 Biden adds voice to calls for further investigation into origins of pandemic virus John Travis
546 [GO] Science 2021―May―27 Two more coronaviruses may infect people Anthony King
547 [GO] Science Advances 2021―May―26 Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses Sham Nambulli, Yufei Xiang, Natasha L. Tilston-Lunel, Linda J. Rennick, Zhe Sang, William B. Klimstra, et al. (+4)
548 [GO] Science Advances 2021―May―26 Lessons from a pandemic for systems-oriented sustainability research Noelle E. Selin
549 [GO] Science 2021―May―25 I’m subject NL002-0060 and I’m dropping out of my COVID-19 vaccine trial Martin Enserink
550 [GO] Science Immunology 2021―May―25 Complement control for COVID-19 Markus Bosmann
551 [GO] Science Immunology 2021―May―25 SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees Daryl Geers, Marc C. Shamier, Susanne Bogers, Gerco den Hartog, Lennert Gommers, Nella N. Nieuwkoop, et al. (+19)
552 [GO] Science 2021―May―25 Estimating infectiousness throughout SARS-CoV-2 infection course Terry C. Jones, Guido Biele, Barbara Mühlemann, Talitha Veith, Julia Schneider, Jörn Beheim-Schwarzbach, et al. (+14)
553 [GO] Science Advances 2021―May―21 Air pollution impacts of COVID-19-related containment measures Guillaume P. Chossière, Haofeng Xu, Yash Dixit, Stewart Isaacs, Sebastian D. Eastham, Florian Allroggen, et al. (+2)
554 [GO] Science 2021―May―21 Blind spots thwart global coronavirus tracking Meredith Wadman
555 [GO] Science 2021―May―21 Two more coronaviruses can infect people, studies suggest Anthony King
556 [GO] Science 2021―May―21 Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants Meng Yuan, Deli Huang, Chang-Chun D. Lee, Nicholas C. Wu, Abigail M. Jackson, Xueyong Zhu, et al. (+11)
557 [GO] Science 2021―May―20 Why is the world’s largest COVID-19 vaccine campaign faltering? Jon Cohen
558 [GO] Science 2021―May―20 Face masks effectively limit the probability of SARS-CoV-2 transmission Yafang Cheng, Nan Ma, Christian Witt, Steffen Rapp, Philipp S. Wild, Meinrat O. Andreae, et al. (+2)
559 [GO] Science 2021―May―18 Human tissue preserved since World War I yields new clues about 1918 pandemic Kai Kupferschmidt
560 [GO] Science 2021―May―18 Forget throat swabs: Dutch company claims its breathalyzer can help sniff out COVID-19 Jop Vrieze
561 [GO] Science Immunology 2021―May―18 Pharmacological activation of STING blocks SARS-CoV-2 infection Minghua Li, Max Ferretti, Baoling Ying, Hélène Descamps, Emily Lee, Mark Dittmar, et al. (+14)
562 [GO] Science Immunology 2021―May―18 A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection Fiachra Humphries, Liraz Shmuel-Galia, Zhaozhao Jiang, Ruth Wilson, Philip Landis, Sze-Ling Ng, et al. (+8)
563 [GO] Science 2021―May―18 Clonal analysis of immunodominance and cross-reactivity of the CD4 T cell response to SARS-CoV-2 Jun Siong Low, Daniela Vaqueirinho, Federico Mele, Mathilde Foglierini, Josipa Jerak, Michela Perotti, et al. (+13)
564 [GO] Science 2021―May―15 Scientists tracking coronavirus variants struggle with global blind spots Meredith Wadman
565 [GO] Science 2021―May―15 The pandemic surge at home is threatening an Indian vaccinemaker’s bid to protect the world Jon Cohen
566 [GO] Science 2021―May―14 Only 1% of Japan is fully vaccinated against COVID-19. Is it ready for the Olympics? Dennis Normile
567 [GO] Science 2021―May―13 ‘A toxic cocktail:’ Panel delivers harsh verdict on the world’s failure to prepare for pandemic Kai Kupferschmidt
568 [GO] Science 2021―May―13 Investigate the origins of COVID-19 Jesse D. Bloom, Yujia Alina Chan, Ralph S. Baric, Pamela J. Bjorkman, Sarah Cobey, Benjamin E. Deverman, et al. (+13)
569 [GO] Science 2021―May―13 Israel's COVID-19 endgame Ran D. Balicer, Reut Ohana
570 [GO] Science 2021―May―13 People with Down syndrome face high risk from coronavirus Meredith Wadman
571 [GO] Science 2021―May―13 Do coronavirus genes slip into human chromosomes? Jon Cohen
572 [GO] Science Immunology 2021―May―13 Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection Lina Ma, Sanjaya K. Sahu, Marlene Cano, Vasanthan Kuppuswamy, Jamal Bajwa, Ja’Nia McPhatter, et al. (+25)
573 [GO] Science 2021―May―13 Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome Pramod R. Bhatt, Alain Scaiola, Gary Loughran, Marc Leibundgut, Annika Kratzel, Romane Meurs, et al. (+8)
574 [GO] Science 2021―May―13 As U.S. pandemic subsides, conferences explore ‘hybrids’ Katie Langin
575 [GO] Science Advances 2021―May―12 Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patients Hyoyoung Jeong, Jong Yoon Lee, KunHyuck Lee, Youn J. Kang, Jin-Tae Kim, Raudel Avila, et al. (+25)
576 [GO] Science 2021―May―07 Further evidence supports controversial claim that SARS-CoV-2 genes can integrate with human DNA Jon Cohen
577 [GO] Science Advances 2021―May―07 The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China Juanjuan Zhang, Maria Litvinova, Yuxia Liang, Wen Zheng, Huilin Shi, Alessandro Vespignani, et al. (+3)
578 [GO] Science 2021―May―06 Polio vaccinators are back after pandemic pause Leslie Roberts
579 [GO] Science 2021―May―06 A community-led approach to COVID-19 Kyle A. Artelle, Kelly Brown, Diana E. Chan, Jennifer J. Silver, Jennifer Sills
580 [GO] Science 2021―May―06 COVID-19 affects HIV and tuberculosis care Quarraisha Abdool Karim, Salim S. Abdool Karim
581 [GO] Science 2021―May―06 COVID-19 complications in South Africa Gemma Alderton, Michael Funk
582 [GO] Science 2021―May―06 Global prospects for COVID-19 control Caroline Ash, Michael Funk
583 [GO] Science 2021―May―06 Nicaragua's COVID-19 crisis demands a response Jorge Huete-Pérez, John Hildebrand, Jennifer Sills
584 [GO] Science 2021―May―06 The COVID-19 pandemic and human fertility A. Aassve, N. Cavalli, L. Mencarini, S. Plach, M. Livi Bacci
585 [GO] Science 2021―May―06 Rapid antigen testing in COVID-19 responses Marta García-Fiñana, Iain E. Buchan
586 [GO] Science 2021―May―06 Is India's coronavirus death ‘paradox’ vanishing? Jon Cohen
587 [GO] Science Advances 2021―May―06 Structural insights into the cross-neutralization of SARS-CoV and SARS-CoV-2 by the human monoclonal antibody 47D11 Juliette Fedry, Daniel L. Hurdiss, Chunyan Wang, Wentao Li, Gonzalo Obal, Ieva Drulyte, et al. (+5)
588 [GO] Science 2021―May―06 A large-scale screen to target SARS-CoV-2 Valda Vinson, Michael Funk
589 [GO] Science 2021―May―06 Data secrecy may cripple U.S. attempts to slow pandemic Charles Piller
590 [GO] Science 2021―May―06 Ecology and economics for pandemic prevention Andrew P. Dobson, Stuart L. Pimm, Lee Hannah, Les Kaufman, Jorge A. Ahumada, Amy W. Ando, et al. (+11)
591 [GO] Science 2021―May―06 Mathematical models to guide pandemic response C. Jessica E. Metcalf, Dylan H. Morris, Sang Woo Park
592 [GO] Science 2021―May―05 ‘There are so many hurdles.’ Indian scientists plead with government to unlock COVID-19 data Priyanka Pulla
593 [GO] Science 2021―May―04 Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes William N. Voss, Yixuan J. Hou, Nicole V. Johnson, George Delidakis, Jin Eyun Kim, Kamyab Javanmardi, et al. (+32)
594 [GO] Science Translational Medicine 2021―May―03 COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters Guilherme Dias de Melo, Françoise Lazarini, Sylvain Levallois, Charlotte Hautefort, Vincent Michel, Florence Larrous, et al. (+15)
595 [GO] Science Translational Medicine 2021―May―03 Viral genomes reveal patterns of the SARS-CoV-2 outbreak in Washington State Nicola F. Müller, Cassia Wagner, Chris D. Frazar, Pavitra Roychoudhury, Jover Lee, Louise H. Moncla, et al. (+37)
596 [GO] Science 2021―May―01 Will India’s devastating COVID-19 surge provide data that clear up its death ‘paradox’? Jon Cohen
597 [GO] Science 2021―May―01 Is Russia’s COVID-19 vaccine safe? Brazil’s veto of Sputnik V sparks lawsuit threat and confusion Sofia Moutinho
598 [GO] Science 2021―Apr―30 Scientists scour the Amazon for pathogens that could spark the next pandemic Daniel Grossman
599 [GO] Science 2021―Apr―30 Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose Catherine J. Reynolds, Corinna Pade, Joseph M. Gibbons, David K. Butler, Ashley D. Otter, Katia Menacho, et al. (+16)
600 [GO] Science 2021―Apr―29 Household COVID-19 risk and in-person schooling Justin Lessler, M. Kate Grabowski, Kyra H. Grantz, Elena Badillo-Goicoechea, C. Jessica E. Metcalf, Carly Lupton-Smith, et al. (+2)
601 [GO] Science 2021―Apr―29 How SARS-CoV-2 first adapted in humans Hyeryun Choe, Michael Farzan
602 [GO] Science 2021―Apr―29 Pandemic haiku Jennifer Sills
603 [GO] Science 2021―Apr―28 COVID-19 ‘brain fog’ inspires search for causes and treatments Kelly Servick
604 [GO] Science 2021―Apr―28 Florida private school threatens jobs of teachers who seek COVID-19 vaccines Meredith Wadman
605 [GO] Science 2021―Apr―28 COVID-19 vaccines may protect many, but not all, people with suppressed immune systems Jennifer Couzin-Frankel
606 [GO] Science 2021―Apr―28 Get your coronavirus test, join the party: Experimental mass events in the Netherlands draw fire Jop Vrieze
607 [GO] Science 2021―Apr―27 Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee, Mauricio Santillana
608 [GO] Science 2021―Apr―23 Resurgence of SARS-CoV-2: detection by community viral surveillance Steven Riley, Kylie E. C. Ainslie, Oliver Eales, Caroline E. Walters, Haowei Wang, Christina Atchison, et al. (+9)
609 [GO] Science 2021―Apr―23 Clear link emerges between COVID-19 and pregnancy complications Jocelyn Kaiser
610 [GO] Science 2021―Apr―23 Do preservative and stray proteins cause rare COVID-19 vaccine side effect? Gretchen Vogel
611 [GO] Science Advances 2021―Apr―23 SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity Annachiara Rosa, Valerie E. Pye, Carl Graham, Luke Muir, Jeffrey Seow, Kevin W. Ng, et al. (+34)
612 [GO] Science 2021―Apr―22 After coronavirus vaccine failures, France laments the state of its biomedical R&D Tania Rabesandratana
613 [GO] Science 2021―Apr―22 Partial immunity and SARS-CoV-2 mutations William P. Hanage, Colin A. Russell, Jennifer Sills
614 [GO] Science 2021―Apr―22 Partial immunity and SARS-CoV-2 mutations-Response Chadi M. Saad-Roy, Sinead E. Morris, C. Jessica E. Metcalf, Michael J. Mina, Rachel E. Baker, Jeremy Farrar, et al. (+7)
615 [GO] Science 2021―Apr―22 Backtracking a pandemic Caroline Ash, Michael Funk
616 [GO] Science 2021―Apr―16 Vaccines that can protect against many coronaviruses could prevent another pandemic Jon Cohen
617 [GO] Science Advances 2021―Apr―16 The SARS-CoV-2 Spike variant D614G favors an open conformational state Rachael A. Mansbach, Srirupa Chakraborty, Kien Nguyen, David C. Montefiori, Bette Korber, S. Gnanakaran
618 [GO] Science Immunology 2021―Apr―15 Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination Rishi R. Goel, Sokratis A. Apostolidis, Mark M. Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, et al. (+25)
619 [GO] Science 2021―Apr―14 Concerns over rare clotting disorders halt use of Johnson & Johnson’s COVID-19 vaccine Gretchen Vogel
620 [GO] Science Immunology 2021―Apr―14 SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8+ T cell activation in COVID-19 patients Sunil Kumar Saini, Ditte Stampe Hersby, Tripti Tamhane, Helle Rus Povlsen, Susana Patricia Amaya Hernandez, Morten Nielsen, et al. (+2)
621 [GO] Science 2021―Apr―14 Spatiotemporal pattern of COVID-19 spread in Brazil Marcia C. Castro, Sun Kim, Lorena Barberia, Ana Freitas Ribeiro, Susie Gurzenda, Karina Braga Ribeiro, et al. (+4)
622 [GO] Science Advances 2021―Apr―14 Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking Marion Schuller, Galen J. Correy, Stefan Gahbauer, Daren Fearon, Taiasean Wu, Roberto Efraín Díaz, et al. (+47)
623 [GO] Science 2021―Apr―14 Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, Ingra M. Claro, Darlan da S. Candido, Swapnil Mishra, et al. (+66)
624 [GO] Science 2021―Apr―14 How scientists are teasing apart the biology of Long COVID Jennifer Couzin-Frankel
625 [GO] Science 2021―Apr―12 Shared B cell memory to coronaviruses and other pathogens varies in human age groups and tissues Fan Yang, Sandra C. A. Nielsen, Ramona A. Hoh, Katharina Röltgen, Oliver Fabian Wirz, Emily Haraguchi, et al. (+13)
626 [GO] Science 2021―Apr―10 Chinese COVID-19 vaccine maintains protection in variant-plagued Brazil Sofia Moutinho
627 [GO] Science 2021―Apr―09 The story behind COVID-19 vaccines Anthony S. Fauci
628 [GO] Science 2021―Apr―07 Russia’s COVID-19 defense may depend on mystery vaccine from former bioweapons lab-but does it work? Olga Dobrovidova
629 [GO] Science Immunology 2021―Apr―07 SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation Bingyu Yan, Tilo Freiwald, Daniel Chauss, Luopin Wang, Erin West, Carmen Mirabelli, et al. (+24)
630 [GO] Science Translational Medicine 2021―Apr―05 The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in non-human primates Bryan E. Jones, Patricia L. Brown-Augsburger, Kizzmekia S. Corbett, Kathryn Westendorf, Julian Davies, Thomas P. Cujec, et al. (+51)
631 [GO] Science 2021―Apr―02 X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease Sebastian Günther, Patrick Y. A. Reinke, Yaiza Fernández-García, Julia Lieske, Thomas J. Lane, Helen M. Ginn, et al. (+96)
632 [GO] Science 2021―Apr―01 ‘Compromise’ WHO report resolves little on pandemic’s origins, but details probe’s next steps Kai Kupferschmidt
633 [GO] Science 2021―Apr―01 Restart science stronger after COVID-19 Alan I. Leshner
634 [GO] Science 2021―Apr―01 Aging immunity may exacerbate COVID-19 Arne N. Akbar, Derek W. Gilroy
635 [GO] Science 2021―Apr―01 COVID-19 policies: Remember measles Debarati Guha-Sapir, Maria Moitinho de Almeida, Mory Keita, Gregg Greenough, Eran Bendavid, Jennifer Sills
636 [GO] Science 2021―Apr―01 SARS-CoV-2 spike protein, elaborated Valda Vinson, Michael Funk
637 [GO] Science 2021―Apr―01 Pandemic scientists fight burnout Meredith Wadman
638 [GO] Science 2021―Apr―01 The pandemic virus is slowly mutating. But does it matter? Kai Kupferschmidt
639 [GO] Science 2021―Mar―30 ‘I’m empty.’ Pandemic scientists are burning out-and don’t see an end in sight Meredith Wadman
640 [GO] Science 2021―Mar―28 A rare clotting disorder may cloud the world's hopes for AstraZeneca's COVID-19 vaccine Kai Kupferschmidt
641 [GO] Science 2021―Mar―27 COVID-19 is soaring again in India. Can vaccines stop it? Vaishnavi Chandrashekhar
642 [GO] Science 2021―Mar―27 Syringe size and supply issues continue to waste COVID-19 vaccine doses in United States Sofia Moutinho
643 [GO] Science 2021―Mar―26 AstraZeneca lowers efficacy claim for COVID-19 vaccine, a bit, after board's rebuke Jon Cohen
644 [GO] Science 2021―Mar―25 mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, Leah J. Homad, Vanessa Rubin, Hayley Glantz, et al. (+13)
645 [GO] Science 2021―Mar―25 The emerging plasticity of SARS-CoV-2 Kevin D. McCormick, Jana L. Jacobs, John W. Mellors
646 [GO] Science 2021―Mar―25 Targeting the SARS-CoV-2 main protease Valda Vinson, Michael Funk
647 [GO] Science 2021―Mar―23 Common fungus emerges as threat to hospitalized COVID-19 patients Nathaniel Scharping
648 [GO] Science 2021―Mar―23 AstraZeneca reports powerful COVID-19 protection in new vaccine trial Kai Kupferschmidt
649 [GO] Science 2021―Mar―23 The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia Martin Pavelka, Kevin Van-Zandvoort, Sam Abbott, Katharine Sherratt, Marek Majdan, Inštitút Zdravotných Analýz, et al. (+4)
650 [GO] Science 2021―Mar―22 Turkey targets critics of its pandemic response Kristen McTighe
651 [GO] Science 2021―Mar―20 Major coronavirus variant found in pets for first time David Grimm
652 [GO] Science 2021―Mar―19 ‘Total game changer’: Pinpointing gene activity in tissues is aiding studies of COVID-19, Alzheimer’s Elizabeth Pennisi
653 [GO] Science 2021―Mar―19 COVID-19 treatment at 1 year, and smarter materials for smarter cities Sarah Crespi
654 [GO] Science 2021―Mar―19 European countries resume use of AstraZeneca’s COVID-19 vaccine, hoping pause has not dented confidence Kai Kupferschmidt
655 [GO] Science 2021―Mar―19 Researchers hunt for cause of rare, COVID-19-linked immune disease in children Jennifer Couzin-Frankel
656 [GO] Science 2021―Mar―19 Amid the pandemic, I learned to reflect on what really matters to me in a career Taylor Wright
657 [GO] Science Advances 2021―Mar―19 Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app Carole H. Sudre, Karla A. Lee, Mary Ni Lochlainn, Thomas Varsavsky, Benjamin Murray, Mark S. Graham, et al. (+27)
658 [GO] Science 2021―Mar―19 Modeling SARS-CoV-2 in mice Priscilla N. Kelly, Michael Funk
659 [GO] Science Advances 2021―Mar―19 Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates Linling He, Xiaohe Lin, Ying Wang, Ciril Abraham, Cindy Sou, Timothy Ngo, et al. (+3)
660 [GO] Science 2021―Mar―18 Many people who die of COVID-19 have the virus in their hearts Emma Yasinski
661 [GO] Science 2021―Mar―18 ‘It’s a very special picture.’ Why vaccine safety experts put the brakes on AstraZeneca’s COVID-19 vaccine Gretchen Vogel
662 [GO] Science 2021―Mar―18 Timing the SARS-CoV-2 index case in Hubei province Jonathan Pekar, Michael Worobey, Niema Moshiri, Konrad Scheffler, Joel O. Wertheim
663 [GO] Science 2021―Mar―18 COVID-19 vaccination passports Christopher Dye, Melinda C. Mills
664 [GO] Science 2021―Mar―18 Appropriate names for COVID-19 variants Salim S. Abdool Karim, Tulio de Oliveira, Glaudina Loots, Jennifer Sills
665 [GO] Science 2021―Mar―18 SARS-CoV-2 transmission without symptoms Angela L. Rasmussen, Saskia V. Popescu
666 [GO] Science 2021―Mar―17 How do you treat coronavirus? Here are physicians’ best strategies Kelly Servick
667 [GO] Science Advances 2021―Mar―17 Catalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2 Noah R. Sundah, Auginia Natalia, Yu Liu, Nicholas R. Y. Ho, Haitao Zhao, Yuan Chen, et al. (+8)
668 [GO] Science 2021―Mar―16 Structural impact on SARS-CoV-2 spike protein by D614G substitution Jun Zhang, Yongfei Cai, Tianshu Xiao, Jianming Lu, Hanqin Peng, Sarah M. Sterling, et al. (+7)
669 [GO] Science Translational Medicine 2021―Mar―15 T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals Tatjana Bilich, Annika Nelde, Jonas S. Heitmann, Yacine Maringer, Malte Roerden, Jens Bauer, et al. (+9)
670 [GO] Science Translational Medicine 2021―Mar―15 SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19 Juan A. Perez-Bermejo, Serah Kang, Sarah J. Rockwood, Camille R. Simoneau, David A. Joy, Ana C. Silva, et al. (+12)
671 [GO] Science 2021―Mar―12 Researchers race to develop antiviral weapons to fight the pandemic coronavirus Robert Service
672 [GO] Science 2021―Mar―11 Critics decry access, transparency issues with key trove of coronavirus sequences Meredith Wadman
673 [GO] Science 2021―Mar―11 What’s in the huge pandemic relief bill for science? David Malakoff
674 [GO] Science 2021―Mar―11 COVID-19 lessons for research Francis S. Collins
675 [GO] Science 2021―Mar―11 Vaccine efficacy probable against COVID-19 variants Larry L. Luchsinger, Christopher D. Hillyer, Jennifer Sills
676 [GO] Science 2021―Mar―11 Coronavirus sequence trove sparks frustration Meredith Wadman
677 [GO] Science 2021―Mar―11 Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape Kevin R. McCarthy, Linda J. Rennick, Sham Nambulli, Lindsey R. Robinson-McCarthy, William G. Bain, Ghady Haidar, W. Paul Duprex
678 [GO] Science 2021―Mar―11 Immunity to SARS-CoV-2 variants of concern Daniel M. Altmann, Rosemary J. Boyton, Rupert Beale
679 [GO] Science 2021―Mar―11 Pandora's pandemic Luis A. Campos
680 [GO] Science Immunology 2021―Mar―10 Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19 Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K Siggins, Felicity Liew, Clark D Russell, Shona C Moore, et al. (+20)
681 [GO] Science Translational Medicine 2021―Mar―10 Academic careers and the COVID-19 pandemic: Reversing the tide Rotonya M. Carr, Meghan B. Lane-Fall, Eugenia South, Donita Brady, Florence Momplaisir, Carmen E. Guerra, et al. (+4)
682 [GO] Science 2021―Mar―10 Countries now scrambling for COVID-19 vaccines may soon have surpluses to donate Jon Cohen
683 [GO] Science 2021―Mar―10 ‘On the verge of a breakdown.’ Report highlights women academics’ pandemic challenges Katie Langin
684 [GO] Science 2021―Mar―09 Health official ousted by Trump to lead private coronavirus tracking effort Jocelyn Kaiser
685 [GO] Science Signaling 2021―Mar―09 Autophagy chokes on SARS-CoV-2 Annalisa M. VanHook
686 [GO] Science 2021―Mar―09 Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes Chadi M. Saad-Roy, Sinead E. Morris, C. Jessica E. Metcalf, Michael J. Mina, Rachel E. Baker, Jeremy Farrar, et al. (+6)
687 [GO] Science 2021―Mar―09 SARS-CoV-2 within-host diversity and transmission Katrina A. Lythgoe, Matthew Hall, Luca Ferretti, Mariateresa de Cesare, George MacIntyre-Cockett, Amy Trebes, et al. (+30)
688 [GO] Science 2021―Mar―08 COVID-19 risks for children Gemma Alderton, Michael Funk
689 [GO] Science 2021―Mar―08 Found: genes that sway the course of the coronavirus Jocelyn Kaiser
690 [GO] Science Advances 2021―Mar―05 An early warning approach to monitor COVID-19 activity with multiple digital traces in near real time Nicole E. Kogan, Leonardo Clemente, Parker Liautaud, Justin Kaashoek, Nicholas B. Link, Andre T. Nguyen, et al. (+11)
691 [GO] Science Advances 2021―Mar―05 Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, Osamu Akasaka, et al. (+17)
692 [GO] Science 2021―Mar―04 International megatrial of coronavirus treatments is at a standstill Kai Kupferschmidt
693 [GO] Science Immunology 2021―Mar―04 SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8+ T cell responses Benedikt Agerer, Maximilian Koblischke, Venugopal Gudipati, Luis Fernando Montaño-Gutierrez, Mark Smyth, Alexandra Popa, et al. (+37)
694 [GO] Science 2021―Mar―03 Critics slam letter in prestigious journal that downplayed COVID-19 risks to Swedish schoolchildren Gretchen Vogel
695 [GO] Science 2021―Mar―03 Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, Christopher I. Jarvis, Adam J. Kucharski, James D. Munday, et al. (+17)
696 [GO] Science Immunology 2021―Mar―02 Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19 Laura A. Vella, Josephine R. Giles, Amy E. Baxter, Derek A. Oldridge, Caroline Diorio, Leticia Kuri-Cervantes, et al. (+33)
697 [GO] Science 2021―Feb―25 Market design to accelerate COVID-19 vaccine supply Juan Camilo Castillo, Amrita Ahuja, Susan Athey, Arthur Baker, Eric Budish, Tasneem Chipty, et al. (+10)
698 [GO] Science 2021―Feb―25 Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A Kris M. White, Romel Rosales, Soner Yildiz, Thomas Kehrer, Lisa Miorin, Elena Moreno, et al. (+20)
699 [GO] Science 2021―Feb―25 SARS-CoV-2 dependence on host pathways Jason P. Wong, Blossom Damania
700 [GO] Science 2021―Feb―24 As trials ramp up, doctors stress need to vaccinate kids against COVID-19 Jennifer Couzin-Frankel
701 [GO] Science 2021―Feb―24 California coronavirus strain may be more infectious-and lethal Meredith Wadman
702 [GO] Science Advances 2021―Feb―24 Supporting women in academia during and after a global pandemic Tiffany A. Reese, Tamia A. Harris-Tryon, Jennifer G. Gill, Laura A. Banaszynski
703 [GO] Science 2021―Feb―23 U.S. National Science Foundation could get $600 million in pandemic relief bill Jeffrey Mervis
704 [GO] Science Immunology 2021―Feb―23 Clonal expansion and activation of tissue-resident memory-like Th17 cells expressing GM-CSF in the lungs of severe COVID-19 patients Yu Zhao, Christoph Kilian, Jan-Eric Turner, Lidia Bosurgi, Kevin Roedl, Patricia Bartsch, et al. (+32)
705 [GO] Science Immunology 2021―Feb―23 Prolonged evolution of the human B cell response to SARS-CoV-2 infection Mrunal Sakharkar, C. Garrett Rappazzo, Wendy F. Wieland-Alter, Ching-Lin Hsieh, Daniel Wrapp, Emma S. Esterman, et al. (+7)
706 [GO] Science Translational Medicine 2021―Feb―22 Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests Netta Barak, Roni Ben-Ami, Tal Sido, Amir Perri, Aviad Shtoyer, Mila Rivkin, et al. (+11)
707 [GO] Science Advances 2021―Feb―22 Immunogenicity of clinically relevant SARS-CoV-2 vaccines in non-human primates and humans P. J. Klasse, Douglas F. Nixon, John P. Moore
708 [GO] Science 2021―Feb―19 Vaccine-wary France turns to citizens’ panel to boost trust in COVID-19 shots Barbara Casassus
709 [GO] Science 2021―Feb―19 All your COVID-19 vaccine questions answered, and a new theory on forming rocky planets Sarah Crespi
710 [GO] Science 2021―Feb―19 A universal coronavirus vaccine Wayne C. Koff, Seth F. Berkley
711 [GO] Science 2021―Feb―19 Mapping antibody escape in SARS-CoV-2 Valda Vinson, Michael Funk
712 [GO] Science 2021―Feb―18 Unprotected African health workers die as rich countries buy up COVID-19 vaccines Kai Kupferschmidt
713 [GO] Science 2021―Feb―18 To aid vaccine research, U.K. approves deliberate infections of volunteers with coronavirus Jon Cohen
714 [GO] Science 2021―Feb―18 SARS-CoV-2 Mpro inhibitors with antiviral activity in a transgenic mouse model Jingxin Qiao, Yue-Shan Li, Rui Zeng, Feng-Liang Liu, Rong-Hua Luo, Chong Huang, et al. (+37)
715 [GO] Science 2021―Feb―17 How soon will COVID-19 vaccines return life to normal? Jon Cohen
716 [GO] Science Advances 2021―Feb―17 An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variants Kui K. Chan, Timothy J. C. Tan, Krishna K. Narayanan, Erik Procko
717 [GO] Science 2021―Feb―17 Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets Rory D. de Vries, Katharina S. Schmitz, Francesca T. Bovier, Camilla Predella, Jonathan Khao, Danny Noack, et al. (+13)
718 [GO] Science 2021―Feb―16 Keeping schools open without masks or quarantines doubled Swedish teachers’ COVID-19 risk Gretchen Vogel
719 [GO] Science 2021―Feb―15 'Politics was always in the room.' WHO mission chief reflects on China trip seeking COVID-19’s origin Kai Kupferschmidt
720 [GO] Science Advances 2021―Feb―14 INSIGHT: A population-scale COVID-19 testing strategy combining point-of-care diagnosis with centralized high-throughput sequencing Qianxin Wu, Chenqu Suo, Tom Brown, Tengyao Wang, Sarah A. Teichmann, Andrew R. Bassett
721 [GO] Science 2021―Feb―14 Should you mix and match COVID-19 vaccines? Scientists are seeking answers Jon Cohen
722 [GO] Science Advances 2021―Feb―14 Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile Carolina Beltrán-Pavez, Sebastián Riquelme-Barrios, Aarón Oyarzún-Arrau, Aracelly Gaete-Argel, Roxana González-Stegmaier, Karina Cereceda-Solis, et al. (+14)
723 [GO] Science 2021―Feb―12 World’s largest COVID-19 drug trial identifies second compound that cuts risk of death Kai Kupferschmidt
724 [GO] Science 2021―Feb―11 Fighting zoonotic coronaviruses Valda Vinson, Michael Funk
725 [GO] Science 2021―Feb―11 Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice Alexander A. Cohen, Priyanthi N. P. Gnanapragasam, Yu E. Lee, Pauline R. Hoffman, Susan Ou, Leesa M. Kakutani, et al. (+7)
726 [GO] Science 2021―Feb―11 A double punch against SARS-CoV-2 Valda Vinson, Michael Funk
727 [GO] Science 2021―Feb―11 Taming a pandemic Caroline Ash, Michael Funk
728 [GO] Science 2021―Feb―11 Pandemic hit academic mothers hard, data show Katie Langin
729 [GO] Science 2021―Feb―11 Tracking the UK SARS-CoV-2 outbreak Martha I. Nelson
730 [GO] Science 2021―Feb―10 U.S. rushes to fill void in viral sequencing as worrisome coronavirus variants spread Meredith Wadman
731 [GO] Science 2021―Feb―10 Pandemic hit academic mothers especially hard, new data confirm Katie Langin
732 [GO] Science 2021―Feb―09 South Africa suspends use of AstraZeneca’s COVID-19 vaccine after it fails to clearly stop virus variant Jon Cohen
733 [GO] Science Advances 2021―Feb―09 A lymph node-targeted Amphiphile vaccine induces potent cellular and humoral immunity to SARS-CoV-2 Martin P. Steinbuck, Lochana M. Seenappa, Aniela Jakubowski, Lisa K. McNeil, Christopher M. Haqq, Peter C. DeMuth
734 [GO] Science Advances 2021―Feb―09 Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression Ke Zhang, Lisa Miorin, Tadashi Makio, Ishmael Dehghan, Shengyan Gao, Yihu Xie, et al. (+13)
735 [GO] Science Advances 2021―Feb―08 Falling living standards during the COVID-19 crisis: Quantitative evidence from nine developing countries Dennis Egger, Edward Miguel, Shana S. Warren, Ashish Shenoy, Elliott Collins, Dean Karlan, et al. (+20)
736 [GO] Science 2021―Feb―05 We paused our Ph.D. research to lead a COVID-19 contact tracing team. Here’s what we learned Nawar Naseer
737 [GO] Science 2021―Feb―04 Danish scientists see tough times ahead as they watch more contagious COVID-19 virus surge Kai Kupferschmidt
738 [GO] Science 2021―Feb―04 ‘A question of choices.’ Pfizer vaccine leader on confronting new coronavirus variants Meredith Wadman
739 [GO] Science 2021―Feb―04 What we’ve learned from communicating our science during the pandemic Esther Choo
740 [GO] Science 2021―Feb―04 Two new vaccines deliver good and bad news for the pandemic Jon Cohen
741 [GO] Science Advances 2021―Feb―03 Leveraging systems biology for predicting modulators of inflammation in patients with COVID-19 Sascha Jung, Ilya Potapov, Samyukta Chillara, Antonio del Sol
742 [GO] Science Advances 2021―Feb―03 A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood Dianna L. Ng, Andrea C. Granados, Yale A. Santos, Venice Servellita, Gregory M. Goldgof, Cem Meydan, et al. (+26)
743 [GO] Science Translational Medicine 2021―Feb―03 Development and deployment of COVID-19 vaccines for those most vulnerable Wayne C. Koff, Theodore Schenkelberg, Tere Williams, Ralph S. Baric, Adrian McDermott, Cheryl M. Cameron, et al. (+13)
744 [GO] Science Advances 2021―Feb―03 Vaccine optimization for COVID-19: Who to vaccinate first? Laura Matrajt, Julia Eaton, Tiffany Leung, Elizabeth R. Brown
745 [GO] Science 2021―Feb―02 Age groups that sustain resurging COVID-19 epidemics in the United States Mélodie Monod, Alexandra Blenkinsop, Xiaoyue Xi, Daniel Hebert, Sivan Bershan, Simon Tietze, et al. (+21)
746 [GO] Science 2021―Jan―30 One-dose COVID-19 vaccine offers solid protection against severe disease Jon Cohen
747 [GO] Science 2021―Jan―30 How do the leading COVID-19 vaccines work? Science explains Meagan Cantwell
748 [GO] Science 2021―Jan―29 This wildlife vet tracks deadly microbes in the African jungle. Now, he’s on the trail of COVID-19 Kai Kupferschmidt
749 [GO] Science 2021―Jan―29 Novavax vaccine delivers 89% efficacy against COVID-19 in U.K.-but is less potent in South Africa Meredith Wadman
750 [GO] Science 2021―Jan―29 Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera Alexander Muik, Ann-Kathrin Wallisch, Bianca Sänger, Kena A. Swanson, Julia Mühl, Wei Chen, et al. (+6)
751 [GO] Science 2021―Jan―28 Insights from SARS-CoV-2 sequences Michael A. Martin, David VanInsberghe, Katia Koelle
752 [GO] Science 2021―Jan―27 Monoclonal antibodies protect against COVID-19 in a second study Jon Cohen
753 [GO] Science 2021―Jan―27 Vaccine 2.0: Moderna and other companies plan tweaks that would protect against new coronavirus mutations Kai Kupferschmidt
754 [GO] Science 2021―Jan―26 Proud of vaccine success, Warp Speed’s ex-science head talks politics, presidents, and future pandemics Jon Cohen
755 [GO] Science Immunology 2021―Jan―25 Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8+ T cells Anthony Kusnadi, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena J Chee, Benjamin J Meckiff, Hayley Simon, et al. (+5)
756 [GO] Science 2021―Jan―25 Prospective mapping of viral mutations that escape antibodies used to treat COVID-19 Tyler N. Starr, Allison J. Greaney, Amin Addetia, William W. Hannon, Manish C. Choudhary, Adam S. Dingens, et al. (+2)
757 [GO] Science 2021―Jan―23 Monoclonal antibodies can prevent COVID-19-but successful vaccines complicate their future Jon Cohen
758 [GO] Science 2021―Jan―22 Media outlets inconsistently mention uncertain status of COVID-19 preprints Cathleen O’Grady
759 [GO] Science 2021―Jan―21 Model-informed COVID-19 vaccine prioritization strategies by age and serostatus Kate M. Bubar, Kyle Reinholt, Stephen M. Kissler, Marc Lipsitch, Sarah Cobey, Yonatan H. Grad, Daniel B. Larremore
760 [GO] Science 2021―Jan―21 Disgraced COVID-19 studies are still routinely cited Charles Piller
761 [GO] Science Translational Medicine 2021―Jan―20 Could COVID-19 eliminate the alarm clock? Jennifer M. Hurley
762 [GO] Science Robotics 2021―Jan―20 How could robotics help establish a new norm after COVID-19? Guang-Zhong Yang
763 [GO] Science 2021―Jan―16 COVID-19 cases are soaring in Indonesia. Can a new health minister turn things around? Dyna Rochmyaningsih
764 [GO] Science 2021―Jan―16 Many scientists citing two scandalous COVID-19 papers ignore their retractions Charles Piller
765 [GO] Science 2021―Jan―16 New coronavirus variants could cause more reinfections, require updated vaccines Kai Kupferschmidt
766 [GO] Science 2021―Jan―16 Biden proposes a science-led New Deal to end pandemic suffering Jon Cohen
767 [GO] Science 2021―Jan―15 How I talk to my science-skeptic parents about COVID-19 Gabriela Goldberg
768 [GO] Science 2021―Jan―15 ‘Compelled by stories.’ A marketing expert’s tips for promoting COVID-19 vaccination Warren Cornwall
769 [GO] Science 2021―Jan―15 Pandemic could mark ‘turning point’ for Chinese science Dennis Normile
770 [GO] Science 2021―Jan―14 After aborted attempt, sensitive WHO mission to study pandemic origins is on its way to China Kai Kupferschmidt
771 [GO] Science 2021―Jan―14 COVID-19 measures also suppress flu-for now Kelly Servick
772 [GO] Science 2021―Jan―14 Could too much time between doses drive the coronavirus to outwit vaccines? Meredith Wadman
773 [GO] Science 2021―Jan―14 Anomalous COVID-19 tests hinder researchers Lindsey R. Robinson-McCarthy, Alexander J. Mijalis, Gabriel T. Filsinger, Helena de Puig, Nina M. Donghia, Thomas E. Schaus, et al. (+17)
774 [GO] Science 2021―Jan―14 Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic Lewis F. Buss, Carlos A. Prete, Claudia M. M. Abrahim, Alfredo Mendrone, Tassila Salomon, Cesar de Almeida-Neto, et al. (+30)
775 [GO] Science 2021―Jan―14 SARS-CoV-2: From entry to autophagy? Leslie K. Ferrarelli, Michael Funk
776 [GO] Science 2021―Jan―14 Pandemic could mark ‘turning point’ for Chinese science Dennis Normile
777 [GO] Science 2021―Jan―14 Saliva could hold clues to how sick you will get from COVID-19 Robert Service
778 [GO] Science Advances 2021―Jan―13 Abrupt but smaller than expected changes in surface air quality attributable to COVID-19 lockdowns Zongbo Shi, Congbo Song, Bowen Liu, Gongda Lu, Jingsha Xu, Tuan Van Vu, et al. (+4)
779 [GO] Science 2021―Jan―13 COVID-19 measures also suppress flu-for now Kelly Servick
780 [GO] Science 2021―Jan―13 Third time’s the charm? Brazil scales back efficacy claims for COVID-19 vaccine from China Jon Cohen
781 [GO] Science 2021―Jan―13 Captive gorillas test positive for coronavirus Ann Gibbons
782 [GO] Science 2021―Jan―12 Immunological characteristics govern the transition of COVID-19 to endemicity Jennie S. Lavine, Ottar N. Bjornstad, Rustom Antia
783 [GO] Science Signaling 2021―Jan―12 Short linear motif candidates in the cell entry system used by SARS-CoV-2 and their potential therapeutic implications Bálint Mészáros, Hugo Sámano-Sánchez, Jesús Alvarado-Valverde, Jelena Čalyševa, Elizabeth Martínez-Pérez, Renato Alves, et al. (+5)
784 [GO] Science Signaling 2021―Jan―12 Cytoplasmic short linear motifs in ACE2 and integrin β3 link SARS-CoV-2 host cell receptors to mediators of endocytosis and autophagy Johanna Kliche, Hanna Kuss, Muhammad Ali, Ylva Ivarsson
785 [GO] Science 2021―Jan―12 Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape Paul-Albert Koenig, Hrishikesh Das, Hejun Liu, Beate M. Kümmerer, Florian N. Gohr, Lea-Marie Jenster, et al. (+24)
786 [GO] Science Immunology 2021―Jan―11 Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection Catherine J. Reynolds, Leo Swadling, Joseph M. Gibbons, Corinna Pade, Melanie P. Jensen, Mariana O. Diniz, et al. (+32)
787 [GO] Science Translational Medicine 2021―Jan―11 Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys Emily Speranza, Brandi N. Williamson, Friederike Feldmann, Gail L. Sturdevant, Lizzette Pérez Pérez, Kimberly Meade-White, et al. (+9)
788 [GO] Science Advances 2021―Jan―08 A smartphone-read ultrasensitive and quantitative saliva test for COVID-19 Bo Ning, Tao Yu, Shengwei Zhang, Zhen Huang, Di Tian, Zhen Lin, et al. (+11)
789 [GO] Science 2021―Jan―08 Brazil announces ‘fantastic’ results for Chinese-made COVID-19 vaccine, but details remain sketchy Jon Cohen
790 [GO] Science 2021―Jan―08 Debates intensify over dosing plans for authorized COVID-19 vaccines Jon Cohen
791 [GO] Science 2021―Jan―08 Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK Louis du Plessis, John T. McCrone, Alexander E. Zarebski, Verity Hill, Christopher Ruis, Bernardo Gutierrez, et al. (+20)
792 [GO] Science 2021―Jan―07 SARS-CoV-2 spillover events Peng Zhou, Zheng-Li Shi
793 [GO] Science 2021―Jan―07 Coevolution of policy and science during the pandemic Yian Yin, Jian Gao, Benjamin F. Jones, Dashun Wang
794 [GO] Science 2021―Jan―07 Viral evolution may herald new pandemic phase Kai Kupferschmidt
795 [GO] Science 2021―Jan―07 ‘What changes is the commitment.’ Biden adviser on the next phase of U.S. pandemic response Jon Cohen
796 [GO] Science Advances 2021―Jan―06 Partisan pandemic: How partisanship and public health concerns affect individuals’ social mobility during COVID-19 J. Clinton, J. Cohen, J. Lapinski, M. Trussler
797 [GO] Science 2021―Jan―06 Scientists criticize ‘rushed’ approval of Indian COVID-19 vaccine without efficacy data Priyanka Pulla
798 [GO] Science 2021―Jan―06 Viral mutations may cause another ‘very, very bad’ COVID-19 wave, scientists warn Kai Kupferschmidt
799 [GO] Science 2021―Jan―06 Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection Jennifer M. Dan, Jose Mateus, Yu Kato, Kathryn M. Hastie, Esther Dawen Yu, Caterina E. Faliti, et al. (+15)
800 [GO] Science Translational Medicine 2021―Jan―04 Stereotypic neutralizing VH antibodies against SARS-CoV-2 spike protein receptor binding domain in COVID-19 patients and healthy individuals Sang Il Kim, Jinsung Noh, Sujeong Kim, Younggeun Choi, Duck Kyun Yoo, Yonghee Lee, et al. (+13)
801 [GO] Science Advances 2021―Jan―01 Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening Daniel B. Larremore, Bryan Wilder, Evan Lester, Soraya Shehata, James M. Burke, James A. Hay, et al. (+3)
802 [GO] Science 2020―Dec―31 COVID-19 and cancer in Africa Beatrice Wiafe Addai, Wilfred Ngwa
803 [GO] Science 2020―Dec―31 The puzzle of the COVID-19 pandemic in Africa Justin M. Maeda, John N. Nkengasong
804 [GO] Science 2020―Dec―31 ‘It’s crazy.’ Upbeat COVID-19 vaccine news from China and U.K. leaves scientists wanting more details Jon Cohen
805 [GO] Science 2020―Dec―31 Avoiding spread of SARS-CoV-2 in cars Karen K. Gleason, Michael Funk
806 [GO] Science 2020―Dec―31 A health economist confronts Kenya's pandemic Linda Nordling
807 [GO] Science 2020―Dec―31 Pandemic progress in Kenya Caroline Ash, Michael Funk
808 [GO] Science 2020―Dec―30 A Kenyan health economist investigates the pandemic’s puzzling course in his country Linda Nordling
809 [GO] Science 2020―Dec―29 Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays Meredith Wadman
810 [GO] Science 2020―Dec―24 U.K. variant puts spotlight on immunocompromised patients’ role in the COVID-19 pandemic Kai Kupferschmidt
811 [GO] Science 2020―Dec―24 COVID-19 testing: One size does not fit all Michael J. Mina, Kristian G. Andersen
812 [GO] Science 2020―Dec―23 Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity Mads Delbo Larsen, Erik L. de Graaf, Myrthe E. Sonneveld, H. Rosina Plomp, Jan Nouta, Willianne Hoepel, et al. (+26)
813 [GO] Science 2020―Dec―23 Makers of successful COVID-19 vaccines wrestle with options for placebo recipients Jon Cohen
814 [GO] Science Immunology 2020―Dec―23 Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence Gemma E. Hartley, Emily S.J. Edwards, Pei M. Aui, Nirupama Varese, Stephanie Stojanovic, James McMahon, et al. (+6)
815 [GO] Science 2020―Dec―22 Suspicions grow that nanoparticles in Pfizer’s COVID-19 vaccine trigger rare allergic reactions Jop Vrieze
816 [GO] Science 2020―Dec―22 Mutant coronavirus in the United Kingdom sets off alarms, but its importance remains unclear Kai Kupferschmidt
817 [GO] Science 2020―Dec―20 Neanderthal gene found in many people may open cells to coronavirus and increase COVID-19 severity Ann Gibbons
818 [GO] Science 2020―Dec―20 Do we need a COVID-19 vaccine for pets? David Grimm
819 [GO] Science 2020―Dec―17 Messenger RNA gave us a COVID-19 vaccine. Will it treat diseases, too? Kelly Servick
820 [GO] Science 2020―Dec―17 The coronavirus may sometimes slip its genetic material into human chromosomes-but what does that mean? Jon Cohen
821 [GO] Science 2020―Dec―16 Inferring the effectiveness of government interventions against COVID-19 Jan M. Brauner, Sören Mindermann, Mrinank Sharma, David Johnston, John Salvatier, Tomáš Gavenčiak, et al. (+13)
822 [GO] Science 2020―Dec―16 COVID-19 is 10 times deadlier for people with Down syndrome, raising calls for early vaccination Meredith Wadman
823 [GO] Science 2020―Dec―16 As COVID-19 vaccines emerge, a global waiting game begins Jon Cohen
824 [GO] Science 2020―Dec―12 Development of unique Australian COVID-19 vaccine halted Dennis Normile
825 [GO] Science 2020―Dec―12 FDA panel backs Pfizer’s COVID-19 vaccine, paving way for emergency use in the United States Jon Cohen
826 [GO] Science 2020―Dec―10 Mexico’s coronavirus czar faces criticism as COVID-19 surges Rodrigo Pérez Ortega
827 [GO] Science 2020―Dec―10 Great efficacy claimed for another COVID-19 vaccine, this one from China Jon Cohen
828 [GO] Science 2020―Dec―10 Mexico's controversial coronavirus czar Rodrigo Pérez Ortega
829 [GO] Science 2020―Dec―10 Remembering seasonal coronaviruses Jenna J. Guthmiller, Patrick C. Wilson
830 [GO] Science 2020―Dec―10 Phylogenetic analysis of SARS-CoV-2 in Boston highlights the impact of superspreading events Jacob E. Lemieux, Katherine J. Siddle, Bennett M. Shaw, Christine Loreth, Stephen F. Schaffner, Adrianne Gladden-Young, et al. (+47)
831 [GO] Science Advances 2020―Dec―09 Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm Philip A. Mudd, Jeremy Chase Crawford, Jackson S. Turner, Aisha Souquette, Daniel Reynolds, Diane Bender, et al. (+13)
832 [GO] Science Translational Medicine 2020―Dec―09 Convalescent plasma in COVID-19: Does use case matter? Girish N. Nadkarni
833 [GO] Science 2020―Dec―08 ‘So many unknowns’: Local doctors-and pharmacies-will still decide who gets COVID-19 vaccines Jon Cohen
834 [GO] Science Translational Medicine 2020―Dec―08 IgA dominates the early neutralizing antibody response to SARS-CoV-2 Delphine Sterlin, Alexis Mathian, Makoto Miyara, Audrey Mohr, François Anna, Laetitia Claër, et al. (+21)
835 [GO] Science Immunology 2020―Dec―08 Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz, Bryan A. Stevens, Catherine A. Hogan, Javaria Najeeb, et al. (+24)
836 [GO] Science Translational Medicine 2020―Dec―08 Enhanced SARS-CoV-2 neutralization by dimeric IgA Zijun Wang, Julio C. C. Lorenzi, Frauke Muecksch, Shlomo Finkin, Charlotte Viant, Christian Gaebler, et al. (+14)
837 [GO] Science Immunology 2020―Dec―05 B careful: Humoral responses and COVID-19 severity Hani Fanous, Angela Guerrero-Pena, Asha Pillai
838 [GO] Science Advances 2020―Dec―05 Differential effects of intervention timing on COVID-19 spread in the United States Sen Pei, Sasikiran Kandula, Jeffrey Shaman
839 [GO] Science Advances 2020―Dec―05 Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM Cong Xu, Yanxing Wang, Caixuan Liu, Chao Zhang, Wenyu Han, Xiaoyu Hong, et al. (+13)
840 [GO] Science 2020―Dec―04 First-of-its-kind African trial tests common drugs to prevent severe COVID-19 Kai Kupferschmidt
841 [GO] Science 2020―Dec―04 COVID-19 vaccine trial ethics once we have efficacious vaccines David Wendler, Jorge Ochoa, Joseph Millum, Christine Grady, Holly A. Taylor
842 [GO] Science 2020―Dec―04 How the new COVID-19 vaccines work, and restoring vision with brain implants Sarah Crespi
843 [GO] Science 2020―Dec―04 How lethal coronaviruses engage hosts Valda Vinson, Michael Funk
844 [GO] Science 2020―Dec―04 A decoy to neutralize SARS-CoV-2 Valda Vinson, Michael Funk
845 [GO] Science 2020―Dec―04 SARS-CoV-2 antibodies persist Seth Thomas Scanlon, Michael Funk
846 [GO] Science 2020―Dec―04 Federal hospital data system falters at tracking pandemic Charles Piller
847 [GO] Science Advances 2020―Dec―03 Satellite-based estimates of decline and rebound in China’s CO2 emissions during COVID-19 pandemic Bo Zheng, Guannan Geng, Philippe Ciais, Steven J. Davis, Randall V. Martin, Jun Meng, et al. (+10)
848 [GO] Science 2020―Dec―03 ‘Wonderful news to wake up to’: U.K. greenlights Pfizer’s COVID-19 vaccine Cathleen O’Grady
849 [GO] Science 2020―Dec―03 CDC advisory panel takes first shot at prioritizing who gets the first shots of COVID-19 vaccines Jon Cohen
850 [GO] Science 2020―Dec―02 Technology Feature | Telemedicine takes center stage in the era of COVID-19 Allison Marin
851 [GO] Science 2020―Dec―02 Epidemiology and transmission dynamics of COVID-19 in two Indian states Ramanan Laxminarayan, Brian Wahl, Shankar Reddy Dudala, K. Gopal, Chandra Mohan B, S. Neelima, et al. (+3)
852 [GO] Science 2020―Dec―02 Coronavirus creates a flu season guessing game Kelly Servick
853 [GO] Science 2020―Dec―02 An antibody cocktail against SARS-CoV-2 Valda Vinson, Michael Funk
854 [GO] Science 2020―Dec―02 Locking down the SARS-CoV-2 spike Valda Vinson, Michael Funk
855 [GO] Science 2020―Dec―02 Protect the giant ibis through the pandemic Hong Yang, Mingguo Ma, Julian R. Thompson, Roger J. Flower, Jennifer Sills
856 [GO] Science 2020―Dec―02 Public health during the pandemic in India Jacob John, Gagandeep Kang
857 [GO] Science 2020―Dec―02 Pandemic lockdown stirs up ecological research Erik Stokstad
858 [GO] Science 2020―Dec―02 Pandemic's fallout on malaria control appears limited so far Leslie Roberts
859 [GO] Science 2020―Dec―01 ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 Jon Cohen
860 [GO] Science Translational Medicine 2020―Dec―01 Lung transplantation for patients with severe COVID-19 Ankit Bharat, Melissa Querrey, Nikolay S. Markov, Samuel Kim, Chitaru Kurihara, Rafael Garza-Castillon, et al. (+9)
861 [GO] Science 2020―Nov―30 Federal system for tracking hospital beds and COVID-19 patients provides questionable data Charles Piller
862 [GO] Science 2020―Nov―27 Modeling, post COVID-19 William H. Press, Richard C. Levin
863 [GO] Science 2020―Nov―27 Keeping coronavirus from spreading in schools, why leaves fall when they do, and a book on how nature deals with crisis Sarah Crespi
864 [GO] Science 2020―Nov―27 Profiling coronaviruses Valda Vinson, Michael Funk
865 [GO] Science 2020―Nov―26 After dosing mix-up, latest COVID-19 vaccine success comes with big question mark Jon Cohen
866 [GO] Science 2020―Nov―26 India needs more transparency in its COVID-19 vaccine trials, critics say Shreya Dasgupta
867 [GO] Science 2020―Nov―26 With global push for COVID-19 vaccines, China aims to win friends and cut deals Jon Cohen
868 [GO] Science 2020―Nov―25 With more data on its COVID-19 vaccine, Russian institute offers new evidence of success Kai Kupferschmidt
869 [GO] Science Signaling 2020―Nov―25 Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1 Aleksandra Milewska, Katherine Falkowski, Magdalena Kulczycka, Ewa Bielecka, Antonina Naskalska, Pawel Mak, et al. (+8)
870 [GO] Science 2020―Nov―24 Another COVID-19 vaccine success? Candidate may prevent further coronavirus transmission, too Jon Cohen
871 [GO] Science Translational Medicine 2020―Nov―24 Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2 Alexandra Popa, Jakob-Wendelin Genger, Michael D. Nicholson, Thomas Penz, Daniela Schmid, Stephan W. Aberle, et al. (+32)
872 [GO] Science 2020―Nov―24 Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 Kaiyuan Sun, Wei Wang, Lidong Gao, Yan Wang, Kaiwei Luo, Lingshuang Ren, et al. (+11)
873 [GO] Science Advances 2020―Nov―21 Damaged lung gas-exchange function of discharged COVID-19 patients detected by hyperpolarized 129Xe MRI Haidong Li, Xiuchao Zhao, Yujin Wang, Xin Lou, Shizhen Chen, He Deng, et al. (+7)
874 [GO] Science 2020―Nov―21 Worlds collide when three Science reporters-and parents-cover coronavirus and schools Jennifer Couzin-Frankel
875 [GO] Science 2020―Nov―21 Should researchers shelve plans to deliberately infect people with the coronavirus? Warren Cornwall
876 [GO] Science 2020―Nov―20 Vaccine wagers on coronavirus surface protein pay off Jon Cohen
877 [GO] Science 2020―Nov―20 A strong cocktail against SARS-CoV-2 Valda Vinson, Michael Funk
878 [GO] Science 2020―Nov―19 As COVID-19 soars in many communities, schools attempt to find ways through the crisis Gretchen Vogel
879 [GO] Science 2020―Nov―19 More people are getting COVID-19 twice, suggesting immunity wanes quickly in some Jop Vrieze
880 [GO] Science 2020―Nov―19 ‘Incredible milestone for science.’ Pfizer and BioNTech update their promising COVID-19 vaccine result Jon Cohen
881 [GO] Science Advances 2020―Nov―19 Social connections with COVID-19-affected areas increase compliance with mobility restrictions Ben Charoenwong, Alan Kwan, Vesa Pursiainen
882 [GO] Science Immunology 2020―Nov―18 The known unknowns of T cell immunity to COVID-19 Annika C. Karlsson, Marion Humbert, Marcus Buggert
883 [GO] Science 2020―Nov―18 The woman playing a key role in a small firm’s quest for an effective COVID-19 vaccine Meagan Cantwell
884 [GO] Science 2020―Nov―17 ‘Just beautiful’: Another COVID-19 vaccine, from newcomer Moderna, s쳮ds in large-scale trial Jon Cohen
885 [GO] Science 2020―Nov―17 Temperature concerns could slow the rollout of new coronavirus vaccines Jocelyn Kaiser
886 [GO] Science 2020―Nov―14 ‘It’s like politicizing toilet paper.’ A member of Biden’s COVID-19 panel surveys the task ahead Warren Cornwall
887 [GO] Science Advances 2020―Nov―14 JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality Justin Stebbing, Ginés Sánchez Nievas, Marco Falcone, Sonia Youhanna, Peter Richardson, Silvia Ottaviani, et al. (+44)
888 [GO] Science 2020―Nov―13 What's next for COVID-19 apps? Governance and oversight Alessandro Blasimme, Effy Vayena
889 [GO] Science 2020―Nov―13 India's COVID-19 teacher Vaishnavi Chandrashekhar
890 [GO] Science 2020―Nov―13 Enhancing host cell infection by SARS-CoV-2 Margaret Kielian
891 [GO] Science 2020―Nov―13 Another host factor for SARS-CoV-2 Stella M. Hurtley, Michael Funk
892 [GO] Science 2020―Nov―13 SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo Yixuan J. Hou, Shiho Chiba, Peter Halfmann, Camille Ehre, Makoto Kuroda, Kenneth H. Dinnon, et al. (+20)
893 [GO] Science 2020―Nov―13 Effective vaccine offers shot of hope for pandemic Jon Cohen
894 [GO] Science 2020―Nov―13 To tackle pandemic, Biden must overcome distrust and division Meredith Wadman, Warren Cornwall
895 [GO] Science 2020―Nov―13 Pandemic dooms Danish mink-and mink research Christa Lesté-Lasserre
896 [GO] Science 2020―Nov―13 The pandemic strengthened my relationship with my supervisor-and prepared us to talk about race Sasha McDowell
897 [GO] Science 2020―Nov―12 Russia’s claim of a successful COVID-19 vaccine doesn’t pass the ‘smell test,’ critics say Jon Cohen
898 [GO] Science 2020―Nov―12 Fact check: No evidence supports Trump’s claim that COVID-19 vaccine result was suppressed to sway election Jon Cohen
899 [GO] Science 2020―Nov―12 Mutant coronaviruses found in mink spark massive culls and doom a Danish group’s research Christa Lesté-Lasserre
900 [GO] Science 2020―Nov―11 Champagne and questions greet first data showing that a COVID-19 vaccine works Jon Cohen
901 [GO] Science 2020―Nov―11 Can a nose-full of chicken antibodies ward off coronavirus infections? Jon Cohen
902 [GO] Science Translational Medicine 2020―Nov―10 Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19 Yu Zuo, Shanea K. Estes, Ramadan A. Ali, Alex A. Gandhi, Srilakshmi Yalavarthi, Hui Shi, et al. (+13)
903 [GO] Science 2020―Nov―10 How a communist physics teacher flattened the COVID-19 curve in southern India Vaishnavi Chandrashekhar
904 [GO] Science 2020―Nov―10 Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans Bas B. Oude Munnink, Reina S. Sikkema, David F. Nieuwenhuijse, Robert Jan Molenaar, Emmanuelle Munger, Richard Molenkamp, et al. (+16)
905 [GO] Science 2020―Nov―10 With inauguration 10 weeks away, Biden’s pandemic plans face agonizing wait Meredith Wadman
906 [GO] Science Advances 2020―Nov―07 Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against Mpro and cathepsin L Michael Dominic Sacco, Chunlong Ma, Panagiotis Lagarias, Ang Gao, Julia Alma Townsend, Xiangzhi Meng, et al. (+11)
907 [GO] Science 2020―Nov―06 Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2 Yufei Xiang, Sham Nambulli, Zhengyun Xiao, Heng Liu, Zhe Sang, W. Paul Duprex, et al. (+3)
908 [GO] Science 2020―Nov―06 De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2 Thomas W. Linsky, Renan Vergara, Nuria Codina, Jorgen W. Nelson, Matthew J. Walker, Wen Su, et al. (+29)
909 [GO] Science 2020―Nov―06 An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike Michael Schoof, Bryan Faust, Reuben A. Saunders, Smriti Sangwan, Veronica Rezelj, Nick Hoppe, et al. (+50)
910 [GO] Science 2020―Nov―06 Preexisting and de novo humoral immunity to SARS-CoV-2 in humans Kevin W. Ng, Nikhil Faulkner, Georgina H. Cornish, Annachiara Rosa, Ruth Harvey, Saira Hussain, et al. (+41)
911 [GO] Science Advances 2020―Nov―05 Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis X. Wu, R. C. Nethery, M. B. Sabath, D. Braun, F. Dominici
912 [GO] Science Advances 2020―Nov―05 How air pollution may influence the course of pandemics Jeremy Jackson, Kip Hodges
913 [GO] Science 2020―Nov―04 Will a small, long-shot U.S. company end up producing the best coronavirus vaccine? Meredith Wadman
914 [GO] Science 2020―Nov―03 COVID-19 recovery funds dwarf clean energy investment needs Marina Andrijevic, Carl-Friedrich Schleussner, Matthew J. Gidden, David L. McCollum, Joeri Rogelj
915 [GO] Science Advances 2020―Oct―30 Fatalities from COVID-19 are reducing Americans’ support for Republicans at every level of federal office Christopher Warshaw, Lynn Vavreck, Ryan Baxter-King
916 [GO] Science 2020―Oct―29 How an immunologist pivoted to tackle COVID-19 Jennifer Couzin-Frankel
917 [GO] Science 2020―Oct―29 Support U.S. research during COVID-19 Michael M. Crow, Jonathan Alger, Michael Amiridis, Dennis Assanis, Eric Barron, Mark P. Becker, et al. (+45)
918 [GO] Science 2020―Oct―29 ‘Another piece of populist propaganda’: Critics slam the Brazilian government’s new COVID-19 drug Herton Escobar
919 [GO] Science 2020―Oct―29 The ‘very, very bad look’ of remdesivir, the first FDA-approved COVID-19 drug Jon Cohen
920 [GO] Science 2020―Oct―29 Factors determining SARS-CoV-2 endemicity Gemma Alderton, Michael Funk
921 [GO] Science 2020―Oct―28 ‘Every minute counts.’ This immunologist rapidly reshaped her lab to tackle COVID-19 Jennifer Couzin-Frankel
922 [GO] Science 2020―Oct―28 Robust neutralizing antibodies to SARS-CoV-2 infection persist for months Ania Wajnberg, Fatima Amanat, Adolfo Firpo, Deena R. Altman, Mark J. Bailey, Mayce Mansour, et al. (+12)
923 [GO] Science 2020―Oct―27 Science’s annual Ph.D. dance contest will go on, with new COVID-19 category Science Staff
924 [GO] Science 2020―Oct―24 ‘There’s only one chance to do this right’-FDA panel wrestles with COVID-19 vaccine issues Jon Cohen
925 [GO] Science 2020―Oct―23 Early approval of a COVID-19 vaccine could cause ethical problems for other vax candidates, and ‘upcycling’ plastic bags Sarah Crespi
926 [GO] Science Advances 2020―Oct―23 Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response Ashish Goyal, E. Fabian Cardozo-Ojeda, Joshua T. Schiffer
927 [GO] Science 2020―Oct―22 The genetics underlying severe COVID-19 Laura M. Zahn, Michael Funk
928 [GO] Science 2020―Oct―22 Susceptibility to severe COVID-19 David B. Beck, Ivona Aksentijevich
929 [GO] Science 2020―Oct―22 Miniproteins against SARS-CoV-2 Valda Vinson, Michael Funk
930 [GO] Science 2020―Oct―22 The engines of SARS-CoV-2 spread Elizabeth C. Lee, Nikolas I. Wada, M. Kate Grabowski, Emily S. Gurley, Justin Lessler
931 [GO] Science 2020―Oct―21 Understanding COVID-19 vaccine efficacy Marc Lipsitch, Natalie E. Dean
932 [GO] Science 2020―Oct―21 Targeting a key enzyme in SARS-CoV-2 Valda Vinson, Michael Funk
933 [GO] Science 2020―Oct―21 Outbreak to pandemic Caroline Ash, Michael Funk
934 [GO] Science 2020―Oct―21 Indigenous communities in Brazil fear pandemic's impact Ignacio Amigo
935 [GO] Science 2020―Oct―20 Could certain COVID-19 vaccines leave people more vulnerable to the AIDS virus? Jon Cohen
936 [GO] Science 2020―Oct―20 Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity Ludovico Cantuti-Castelvetri, Ravi Ojha, Liliana D. Pedro, Minou Djannatian, Jonas Franz, Suvi Kuivanen, et al. (+23)
937 [GO] Science 2020―Oct―20 Neuropilin-1 is a host factor for SARS-CoV-2 infection James L. Daly, Boris Simonetti, Katja Klein, Kai-En Chen, Maia Kavanagh Williamson, Carlos Antón-Plágaro, et al. (+15)
938 [GO] Science 2020―Oct―20 Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate Sandhya Bangaru, Gabriel Ozorowski, Hannah L. Turner, Aleksandar Antanasijevic, Deli Huang, Xiaoning Wang, et al. (+12)
939 [GO] Science Translational Medicine 2020―Oct―19 Prospects for a safe COVID-19 vaccine Barton F. Haynes, Lawrence Corey, Prabhavathi Fernandes, Peter B. Gilbert, Peter J. Hotez, Srinivas Rao, et al. (+4)
940 [GO] Science 2020―Oct―17 Remdesivir and interferon fall flat in WHO’s megastudy of COVID-19 treatments Kai Kupferschmidt
941 [GO] Science 2020―Oct―16 ‘A fraud on the nation’: critics blast Indian government’s promotion of traditional medicine for COVID-19 Priyanka Pulla
942 [GO] Science 2020―Oct―16 Making sure American Indian COVID-19 cases are counted, and feeding a hungry heart Sarah Crespi
943 [GO] Science 2020―Oct―16 Act now, wait for perfect evidence later, says ‘high priestess’ of U.K. COVID-19 masking campaign Ellen Shell
944 [GO] Science 2020―Oct―16 Spit shines for easier coronavirus testing Robert F. Service
945 [GO] Science 2020―Oct―16 Inhibiting Ebola virus and SARS-CoV-2 entry Alexandra I. Wells, Carolyn B. Coyne
946 [GO] Science Advances 2020―Oct―16 Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design Wioletta Rut, Zongyang Lv, Mikolaj Zmudzinski, Stephanie Patchett, Digant Nayak, Scott J. Snipas, et al. (+5)
947 [GO] Science 2020―Oct―16 A pandemic journey Sergio E. Ramos
948 [GO] Science 2020―Oct―15 The ‘bat man’ tackles COVID-19 Kai Kupferschmidt
949 [GO] Science 2020―Oct―15 The inside story of how Trump’s COVID-19 coordinator undermined the world’s top health agency Charles Piller
950 [GO] Science 2020―Oct―15 Early approval of a COVID-19 vaccine could stymie the hunt for better ones Jon Cohen
951 [GO] Science 2020―Oct―15 Preexisting immune response to SARS-CoV-2 Priscilla N. Kelly, Michael Funk
952 [GO] Science 2020―Oct―15 How SARS-CoV-2 hides its mRNA Annalisa M. VanHook, Michael Funk
953 [GO] Science 2020―Oct―14 Found: genes that sway the course of the coronavirus Jocelyn Kaiser
954 [GO] Science 2020―Oct―14 Will SARS-CoV-2 become endemic? Jeffrey Shaman, Marta Galanti
955 [GO] Science 2020―Oct―09 Researchers face hurdles to evaluate, synthesize COVID-19 evidence at top speed Jeffrey Brainard
956 [GO] Science 2020―Oct―09 New test detects coronavirus in just 5 minutes Robert Service
957 [GO] Science Advances 2020―Oct―09 Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Yuanmei Zhu, Danwei Yu, Yang Han, Hongxia Yan, Huihui Chong, Lili Ren, et al. (+3)
958 [GO] Science 2020―Oct―09 REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters Alina Baum, Dharani Ajithdoss, Richard Copin, Anbo Zhou, Kathryn Lanza, Nicole Negron, et al. (+30)
959 [GO] Science 2020―Oct―09 I benefited from being an international scientist in the U.S.-until the pandemic Sergio E. Ramos
960 [GO] Science Immunology 2020―Oct―08 Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients Anita S. Iyer, Forrest K. Jones, Ariana Nodoushani, Meagan Kelly, Margaret Becker, Damien Slater, et al. (+29)
961 [GO] Science 2020―Oct―08 Saying human trials aren’t enough, researchers call for comparison of COVID-19 vaccines in monkeys Jon Cohen
962 [GO] Science 2020―Oct―08 Calm down about political ‘mischief’ around COVID-19 vaccines, scientists say Jon Cohen
963 [GO] Science 2020―Oct―07 ‘It’s been so, so surreal.’ Critics of Sweden’s lax pandemic policies face fierce backlash Gretchen Vogel
964 [GO] Science 2020―Oct―07 Amid pandemic, U.S. faculty job openings plummet Katie Langin
965 [GO] Science 2020―Oct―05 Airborne transmission of SARS-CoV-2 Kimberly A. Prather, Linsey C. Marr, Robert T. Schooley, Melissa A. McDiarmid, Mary E. Wilson, Donald K. Milton
966 [GO] Science 2020―Oct―04 Update: Here’s what is known about Trump’s COVID-19 treatment Jon Cohen
967 [GO] Science 2020―Oct―04 Why Anthony Fauci is happy being the "skunk" on the Coronavirus Task Force Jon Cohen
968 [GO] Science 2020―Oct―03 How might President Donald Trump fare with COVID-19? Jennifer Couzin-Frankel
969 [GO] Science 2020―Oct―01 ‘Provocative results’ boost hopes of antibody treatment for COVID-19 Jon Cohen
970 [GO] Science 2020―Sep―30 One number could help reveal how infectious a COVID-19 patient is. Should test results include it? Robert Service
971 [GO] Science 2020―Sep―30 How stigmatizing disease-from COVID-19 to HIV-creates a vicious cycle of sickness Joel Goldberg
972 [GO] Science 2020―Sep―30 On the road with Operation Warp Speed, the U.S. COVID-19 vaccine effort Jon Cohen
973 [GO] Science 2020―Sep―29 Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity Ellen Shrock, Eric Fujimura, Tomasz Kula, Richard T. Timms, I-Hsiu Lee, Yumei Leng, et al. (+30)
974 [GO] Science Signaling 2020―Sep―29 High-resolution structures of the SARS-CoV-2 2′-O-methyltransferase reveal strategies for structure-based inhibitor design Monica Rosas-Lemus, George Minasov, Ludmilla Shuvalova, Nicole L. Inniss, Olga Kiryukhina, Joseph Brunzelle, Karla J. F. Satchell
975 [GO] Science Immunology 2020―Sep―28 MAIT cell activation and dynamics associated with COVID-19 disease severity Tiphaine Parrot, Jean-Baptiste Gorin, Andrea Ponzetta, Kimia T. Maleki, Tobias Kammann, Johanna Emgård, et al. (+15)
976 [GO] Science 2020―Sep―25 COVID-19 data on Native Americans is ‘a national disgrace.’ This scientist is fighting to be counted Lizzie Wade
977 [GO] Science Advances 2020―Sep―25 Model uncertainty, political contestation, and public trust in science: Evidence from the COVID-19 pandemic S.E. Kreps, D. L. Kriner
978 [GO] Science 2020―Sep―25 Hidden immune weakness found in 14% of gravely ill COVID-19 patients Meredith Wadman
979 [GO] Science 2020―Sep―25 When COVID-19 silenced cities, birdsong recaptured its former glory Erik Stokstad
980 [GO] Science 2020―Sep―24 Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 Paul Bastard, Lindsey B. Rosen, Qian Zhang, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Yu Zhang, et al. (+93)
981 [GO] Science 2020―Sep―24 Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Qian Zhang, Paul Bastard, Zhiyong Liu, Jérémie Le Pen, Marcela Moncada-Velez, Jie Chen, et al. (+123)
982 [GO] Science 2020―Sep―24 COVID-19 can affect the heart Eric J. Topol
983 [GO] Science 2020―Sep―24 Singing in a silent spring: Birds respond to a half-century soundscape reversion during the COVID-19 shutdown Elizabeth P. Derryberry, Jennifer N. Phillips, Graham E. Derryberry, Michael J. Blum, David Luther
984 [GO] Science 2020―Sep―24 Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp, Dora Pinto, Ha V. Dang, Laura E. Rosen, et al. (+41)
985 [GO] Science Advances 2020―Sep―23 The unfolding COVID-19 pandemic: A probability-based, nationally representative study of mental health in the U.S. E. Alison Holman, Rebecca R. Thompson, Dana Rose Garfin, Roxane Cohen Silver
986 [GO] Science 2020―Sep―23 ‘I just want this suffering to be over.’ Brazilians flock to COVID-19 vaccine trials Herton Escobar
987 [GO] Science 2020―Sep―22 WHO unveils global plan to fairly distribute COVID-19 vaccine, but challenges await Kai Kupferschmidt
988 [GO] Science 2020―Sep―21 COVID-19 in children and young people Matthew D. Snape, Russell M. Viner
989 [GO] Science Translational Medicine 2020―Sep―21 Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients Carl A. Pierce, Paula Preston-Hurlburt, Yile Dai, Clare Burn Aschner, Natalia Cheshenko, Benjamin Galen, et al. (+13)
990 [GO] Science 2020―Sep―21 Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years Chadi M. Saad-Roy, Caroline E. Wagner, Rachel E. Baker, Sinead E. Morris, Jeremy Farrar, Andrea L. Graham, et al. (+4)
991 [GO] Science 2020―Sep―21 Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein Christine Toelzer, Kapil Gupta, Sathish K. N. Yadav, Ufuk Borucu, Andrew D. Davidson, Maia Kavanagh Williamson, et al. (+10)
992 [GO] Science 2020―Sep―19 COVID-19 data scandal prompts tweaks to elite journal’s review process Kelly Servick
993 [GO] Science Advances 2020―Sep―18 Antibody-like proteins that capture and neutralize SARS-CoV-2 T. Kondo, Y. Iwatani, K. Matsuoka, T. Fujino, S. Umemoto, Y. Yokomaku, et al. (+5)
994 [GO] Science 2020―Sep―18 Pandemic inspires new push to shrink jails and prisons Kelly Servick
995 [GO] Science 2020―Sep―18 Performing magic for animals, and why the pandemic is pushing people out of prisons Sarah Crespi
996 [GO] Science 2020―Sep―18 I’m a scientist making a difference during the pandemic-as a letter carrier Dennis Macejak
997 [GO] Science Immunology 2020―Sep―17 Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19 Elizabeth R. Mann, Madhvi Menon, Sean Blandin Knight, Joanne E. Konkel, Christopher Jagger, Tovah N. Shaw, et al. (+12)
998 [GO] Science 2020―Sep―17 University-pharmacy partnerships for COVID-19 Vincent J. Venditto, Brooke Hudspeth, Patricia R. Freeman, Clark Kebodeaux, R. Kiplin Guy, Jennifer Sills
999 [GO] Science 2020―Sep―17 Eli Lilly reports promising first results for an antibody against COVID-19 Meredith Wadman
1000 [GO] Science 2020―Sep―17 From leprosy to COVID-19, how stigma makes it harder to fight epidemics Vaishnavi Chandrashekhar
1001 [GO] Science 2020―Sep―17 Turkish scientists and physicians face criminal investigations after criticizing COVID-19 policies Kristen McTighe
1002 [GO] Science 2020―Sep―17 An ‘uncoordinated’ immune response may explain why COVID-19 strikes some hard, particularly the elderly Jon Cohen
1003 [GO] Science 2020―Sep―17 A steric block to SARS-CoV-2 Valda Vinson, Michael Funk
1004 [GO] Science 2020―Sep―17 Stabilizing the prefusion SARS-CoV-2 spike Valda Vinson, Michael Funk
1005 [GO] Science 2020―Sep―17 Pandemic inspires push to shrink jails, prisons Kelly Servick
1006 [GO] Science 2020―Sep―16 As evidence builds that COVID-19 can damage the heart, doctors are racing to understand it Jennifer Couzin-Frankel
1007 [GO] Science Advances 2020―Sep―16 Reimagining scientific conferences during the pandemic and beyond Thale Jarvis, Shannon Weiman, Deborah Johnson
1008 [GO] Science 2020―Sep―15 Ethical or exploitative-should prisoners participate in COVID-19 vaccine trials? Eli Cahan
1009 [GO] Science Signaling 2020―Sep―15 COVID-19: All the wrong moves in all the wrong places Christopher D. Barrett, Michael B. Yaffe
1010 [GO] Science 2020―Sep―12 COVID-19 worries douse plans for fire experiments Eli Cahan
1011 [GO] Science 2020―Sep―11 To fight COVID-19, a young epidemiologist bridges the gulf between science and U.S. politics Kelly Servick
1012 [GO] Science Advances 2020―Sep―11 Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease Cintia A. Menéndez, Fabian Byléhn, Gustavo R. Perez-Lemus, Walter Alvarado, Juan J. de Pablo
1013 [GO] Science 2020―Sep―10 Accumulation of plastic waste during COVID-19 Tanveer M. Adyel, Jennifer Sills
1014 [GO] Science 2020―Sep―10 Why obesity worsens COVID-19 Meredith Wadman
1015 [GO] Science 2020―Sep―10 Coronavirus dons a new crown Nuruddin Unchwaniwala, Paul Ahlquist
1016 [GO] Science 2020―Sep―10 The emergence of SARS-CoV-2 in Europe and North America Michael Worobey, Jonathan Pekar, Brendan B. Larsen, Martha I. Nelson, Verity Hill, Jeffrey B. Joy, et al. (+4)
1017 [GO] Science 2020―Sep―10 Cryptic transmission of SARS-CoV-2 in Washington state Trevor Bedford, Alexander L. Greninger, Pavitra Roychoudhury, Lea M. Starita, Michael Famulare, Meei-Li Huang, et al. (+50)
1018 [GO] Science 2020―Sep―09 Why COVID-19 is more deadly in people with obesity-even if they're young Meredith Wadman
1019 [GO] Science 2020―Sep―09 De novo design of picomolar SARS-CoV-2 miniprotein inhibitors Longxing Cao, Inna Goreshnik, Brian Coventry, James Brett Case, Lauren Miller, Lisa Kozodoy, et al. (+9)
1020 [GO] Science 2020―Sep―05 Can you catch COVID-19 from your neighbor’s toilet? Jocelyn Kaiser
1021 [GO] Science 2020―Sep―05 As the pandemic erodes grad student mental health, academics sound the alarm Katie Langin
1022 [GO] Science 2020―Sep―04 Fighting Europe’s second wave of COVID-19, and making democracy work for poor people Sarah Crespi
1023 [GO] Science 2020―Sep―03 Reopening schools during COVID-19 Ronan Lordan, Garret A. FitzGerald, Tilo Grosser
1024 [GO] Science 2020―Sep―03 A molecular trap against COVID-19 Brandon J. DeKosky
1025 [GO] Science 2020―Sep―03 Immune profiling of COVID-19 patients Priscilla N. Kelly, Michael Funk
1026 [GO] Science 2020―Sep―03 A decoy receptor for SARS-CoV-2 Valda Vinson, Michael Funk
1027 [GO] Science 2020―Sep―03 The spread of SARS-CoV-2 in Brazil Caroline Ash, Michael Funk
1028 [GO] Science 2020―Sep―03 Can Europe tame the pandemic's next wave? Kai Kupferschmidt
1029 [GO] Science Advances 2020―Sep―02 Continuous on-body sensing for the COVID-19 pandemic: Gaps and opportunities Hyoyoung Jeong, John A. Rogers, Shuai Xu
1030 [GO] Science 2020―Sep―02 Can Europe tame the pandemic’s next wave? Kai Kupferschmidt
1031 [GO] Science 2020―Aug―29 Here’s how the U.S. could release a COVID-19 vaccine before the election-and why that scares some Jon Cohen
1032 [GO] Science 2020―Aug―28 How Italy’s ‘father of the swabs’ fought the coronavirus Douglas Starr
1033 [GO] Science 2020―Aug―28 In ‘milestone,’ FDA OKs simple, accurate coronavirus test that could cost just $5 Robert Service
1034 [GO] Science 2020―Aug―27 The coronavirus may shut down the immune system’s vital classrooms Jon Cohen
1035 [GO] Science 2020―Aug―27 MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses Anna Bruchez, Ky Sha, Joshua Johnson, Li Chen, Caroline Stefani, Hannah McConnell, et al. (+9)
1036 [GO] Science Signaling 2020―Aug―25 Growth factors and SARS-CoV-2 John F. Foley
1037 [GO] Science 2020―Aug―21 Grad students challenge university-mandated COVID-19 agreements Katie Langin
1038 [GO] Science Immunology 2020―Aug―21 Natural killer cell immunotypes related to COVID-19 disease severity Christopher Maucourant, Iva Filipovic, Andrea Ponzetta, Soo Aleman, Martin Cornillet, Laura Hertwig, et al. (+22)
1039 [GO] Science Advances 2020―Aug―21 Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers Noam Shental, Shlomia Levy, Vered Wuvshet, Shosh Skorniakov, Bar Shalem, Aner Ottolenghi, et al. (+12)
1040 [GO] Science 2020―Aug―20 NIH imposes ‘outrageous’ conditions on resuming coronavirus grant targeted by Trump Meredith Wadman
1041 [GO] Science 2020―Aug―19 COVID-19 hits U.S. mink farms after ripping through Europe Eli Cahan
1042 [GO]